C

o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
745 745 745 745 745
Dosages of Some Common Drugs
745
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
S
.
N
a
m
e

o
f

t
h
e

D
r
u
g
A
g
e

G
r
o
u
p
R
o
u
t
e
T
o
t
a
l

D
o
s
e
D
o
s
a
g
e
P
r
e
p
a
r
a
t
i
o
n
S
t
r
e
n
g
t
h
R
e
m
a
r
k
s
N
o
.
(
D
o
s
a
g
e
(
D
u
r
a
t
i
o
n
(
m
g
/
k
g
/
2
4

h
r
i
n
t
e
r
v
a
l
(
S
y
r
/
S
u
s
p
.
/
L
i
q
.
(
C
/
I
-
C
o
n
t
r
a
i
n
d
i
c
a
t
i
o
n
s
)
m
o
d
i
f
i
c
a
t
i
o
n
o
f

I
V

d
o
s
e
u
n
l
e
s
s

o
t
h
e
r
(
H
o
u
r
s
)
m
g
/
p
e
r

5

m
L
)
n
e
c
e
s
s
a
r
y

i
n
i
n
f
u
s
i
o
n

i
n
w
i
s
e

s
t
a
t
e
d
)
D
r
o
p
s

A
m
p
s
R

=

R
e
n
a
l

F
a
i
l
u
r
e
p
a
r
e
n
t
h
e
s
i
s
)
m
g
/
m
l

T
a
b
s
/
H

=

H
e
p
a
t
i
c

F
a
i
l
u
r
e
)
C
a
p

i
n

m
g
T
o
t
a
l

V
i
a
l
s
-
c
o
n
t
e
n
t

i
n

m
g
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
1
.
A
c
e
t
a
m
i
n
o
p
h
e
n
N
B
P
O
5

m
g
/
k
g
/
d
o
s
e
4
D
r
o
p
s
1
0
0
,

1
5
0
A
n
a
l
g
e
s
i
c
,

a
n
t
i
p
y
r
e
t
i
c

b
u
t

n
o
t
(
R
,
H
)
a
n
t
i
-
i
n
f
l
a
m
m
a
t
o
r
y
.
(
P
a
r
a
c
e
t
a
m
o
l
)
I
N
,

C
H
P
O
6
0
4
-
6

P
R
N
.
S
y
r
/
S
u
s
p
1
2
0
M
o
d
e
r
a
t
e

o
v
e
r
d
o
s
e
-
I
M
5

m
g
/
k
g
/
d
o
s
e
T
a
b
5
0
0
,

6
5
0
h
y
p
o
g
l
y
c
e
m
i
a
,

d
i
z
z
i
n
e
s
s
,
A
m
p
1
5
0
d
i
s
o
r
i
e
n
t
a
t
i
o
n
,

r
e
v
e
r
s
i
b
l
e
j
a
u
n
d
i
c
e
.
M
a
s
s
i
v
e

o
v
e
r
d
o
s
e
-
H
e
p
a
t
i
c
n
e
c
r
o
s
i
s
.
A
n
t
i
d
o
t
e
-
N
-
a
c
e
t
y
l
c
y
s
t
e
i
n
e
.
2
.
A
c
e
t
a
z
o
l
a
m
i
d
e

(
R
)
H
y
d
r
o
c
e
p
h
a
l
u
s
I
N
,

C
H
3
0
-
5
0
6
-
8
T
a
b
2
5
0
A
s

a
d
j
u
n
c
t

t
o
I
N
,

C
H
P
O
8
-
3
0
6
-
1
2
a
n
t
i
e
p
i
l
e
p
t
i
c

d
r
u
g
s
3
.
A
c
e
t
y
l
c
y
s
t
e
i
n
e

(
H
)
I
N
,

C
H
I
V
1
4
0

m
g
/

k
g
4

h
r
l
y
A
m
p
2
0
0
A
n
t
i
d
o
t
e

f
o
r
l
o
a
d
i
n
g

d
o
s
e
,
a
c
e
t
a
m
i
n
o
p
h
e
n
f
o
l
l
o
w
e
d

b
y
t
o
x
i
c
i
t
y
7
0

m
g
/
k
g
/
d
o
s
e
e
v
e
r
y

4

h
o
u
r
s
f
o
r

a

t
o
t
a
l

o
f
1
7

d
o
s
e
s
4
.
A
C
T
H
I
N
,

C
H
I
M
,
5
-
8

U
/
k
g
/
d
a
y
1
2
-
2
4
R
e
p
o
s
i
t
o
r
y

g
e
l
2
0

U
C
/
I

C
H
F
.

O
c
u
l
a
r

h
e
r
p
e
s
.
S
C
4
0

U
G
e
l

s
t
o
r
e
d

r
e
f
r
i
g
e
r
a
t
e
d
.

W
a
r
m
8
0

U
t
o

r
o
o
m

t
e
m
p
.

b
e
f
o
r
e

u
s
e
.
5
.
A
c
y
c
l
o
v
i
r

(
R
)
T
a
b
2
0
0
,

4
0
0
,

8
0
0
H
e
r
p
e
s

e
n
c
e
p
h
a
l
i
t
i
s
N
B
,

I
N
,
I
V
3
0
-
4
5
8
V
i
a
l
2
5
0
C
H
(
6
0

m
i
n
)
5
0
0

m
g
/
m
2
/
d
o
s
e
8
V
a
r
i
c
e
l
l
a
-
z
o
s
t
e
r
C
H
P
O
2
0

m
g
/
k
g
/
d
o
s
e
6
6
.
A
d
e
n
i
n
e

a
r
a
b
i
n
o
s
i
d
e
N
B
I
V
1
5
-
3
0
C
o
n
s
t
a
n
t
A
m
p
2
0
0
F
o
r

H
e
r
p
e
s

s
i
m
p
l
e
x

i
n
f
e
c
t
i
o
n
s
(
V
i
d
a
r
a
b
i
n
e
)
I
N
,
I
V
1
5
i
n
f
u
s
i
o
n
r
e
s
i
s
t
a
n
t

t
o

a
c
y
c
l
o
v
i
r
.
C
H
F
o
r

1
2

h
r
p
e
r

d
a
y

1
0

d
a
y
s
A
n
n
e
x
u
r
e

I
:

D
o
s
a
g
e
s

o
f

S
o
m
e

C
o
m
m
o
n

D
r
u
g
s
A
s
h
o
k

K

D
e
o
r
a
r
i
,

R
a
k
e
s
h

L
o
d
h
a
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
Principles of Pediatric and Neonatal Emergencies
746
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
7
.
A
d
e
n
o
s
i
n
e
N
B
I
V
0
.
0
5

m
g
/
k
g

I
V

A
m
p
3

m
g
M
a
y

c
a
u
s
e
P
S
V
T
I
N
p
u
s
h
,

i
n
c
r
e
a
s
e
b
r
o
n
c
h
o
c
o
n
s
t
r
i
c
t
i
o
n

i
n
C
H
b
o
l
u
s

d
o
s
e

b
y
a
s
t
h
m
a
t
i
c
s
.
0
.
0
5

m
g
/
k
g

e
v
e
r
y
C
o
n
t
i
n
u
o
u
s

E
C
G
,

B
P
,

R
R
2

m
i
n

t
i
l
l

c
l
i
n
i
c
a
l
m
o
n
i
t
o
r
i
n
g

r
e
q
u
i
r
e
d
.
r
e
s
p
o
n
s
e
(
m
a
x

d
o
s
e

1
2

m
g
)
8
.
A
d
r
e
n
a
l
i
n
e
B
r
o
n
c
h
o
d
i
l
a
t
o
r
I
N
,

C
H
S
C
0
.
0
1

m
l
/
k
g
/
d
o
s
e
A
m
p

o
f
1

m
L

=

1

m
g
M
a
y

b
e

r
e
p
e
a
t
e
d
R
e
s
u
s
c
i
t
a
t
i
o
n
N
B
,

I
N
,

C
H
I
V
,
0
.
1

m
l
/
k
g

o
f
1
:
1
0
0
0
a
f
t
e
r

1
5
-
2
0

m
i
n
u
t
e
s
I
n
t
r
a
t
r
a
c
h
e
a
l
1
:
1
0
,
0
0
0
S
o
l
n
f
o
r

1
-
2

d
o
s
e
s
.

1
:
1
0
0
0
0
N
e
b
u
l
i
z
a
t
i
o
n
p
r
e
p
a
r
a
t
i
o
n

n
e
e
d
e
d

f
o
r

I
V

a
n
d
e
n
d
o
t
r
a
c
h
e
a
l

u
s
e
;

p
r
e
p
a
r
e

b
y
d
i
l
u
t
i
n
g

w
i
t
h

n
o
r
m
a
l

s
a
l
i
n
e
.
U
n
s
t
a
b
l
e

i
n

a
l
k
a
l
i
n
e

s
o
l
u
t
i
o
n
s
.
9
.
A
l
b
u
m
i
n
N
B
,

I
N
,

C
H
I
V
0
.
5
-
1

g
/
k
g
/
d
o
s
e
S
o
l
n
5
%
1
0
%
2
5
%
1
0
.
A
m
i
k
a
c
i
n

(
R
)
N
B
,

I
N
I
M
,

I
V
S
e
e

n
e
w
b
o
r
n
8
V
i
a
l
1
0
0
,

2
5
0
,

5
0
0
A
u
d
i
t
o
r
y

a
n
d

n
e
p
h
r
o
t
o
x
i
c
.
T
a
b
l
e
T
o
x
i
c
i
t
y

i
s

p
o
t
e
n
t
i
a
t
e
d

b
y
C
H
I
M
,

I
V
1
5
-
2
5
c
o
n
c
o
m
i
t
a
n
t

u
s
e

o
f

o
t
h
e
r
n
e
p
h
r
o
t
o
x
i
c

d
r
u
g
s
,

a
n
d
f
u
r
o
s
e
m
i
d
e
.
1
1
.
A
m
i
o
d
a
r
o
n
e

(
H
)
I
N
,

C
H
I
V
5

m
g
/
k
g

o
v
e
r
A
m
p
1
5
0

m
g
/

3

m
L
3
0

m
i
n

f
o
l
l
o
w
e
d
b
y

c
o
n
t
i
n
u
o
u
s
i
n
f
u
s
i
o
n

a
t

t
h
e
r
a
t
e

o
f

5

g
/

k
g
/
m
i
n

(
m
a
x

d
o
s
e

o
f
1
5

g
/

k
g
/
m
i
n

o
r
2
0

m
g
/
k
g
/

2
4

h
r
)
1
2
.
A
m
i
n
o
p
h
y
l
l
i
n
e
I
N
,

C
H
I
V
5

m
g
/
k
g
/
d
o
s
e
6
A
m
p
1
0
0
N
o

l
o
a
d
i
n
g

d
o
s
e

f
o
r

p
a
t
i
e
n
t
s
L
o
a
d
i
n
g
(
5
-
1
5

m
i
n
s
)
a
l
r
e
a
d
y

o
n

o
r
a
l

t
h
e
o
p
h
y
l
l
i
n
e
.
M
a
i
n
t
e
n
a
n
c
e
I
N
,

C
H
I
V
1
5
-
2
0

(
c
o
n
t
i
n
u
o
u
s
6
-
8
i
n
f
u
s
i
o
n
)
A
p
n
e
a

o
f

p
r
e
m
a
t
u
r
i
t
y
P
r
e
t
e
r
m
I
V
5

m
g
/
k
g
/

l
o
a
d
i
n
g
8
f
o
l
l
o
w
e
d
2

m
g
/
k
g
/
d
o
s
e
b
y

I
V
/
P
O
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
747 747 747 747 747
Dosages of Some Common Drugs
747
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
1
3
.
A
m
l
o
d
e
p
i
n

(
H
)
C
H
P
O
0
.
1
-

0
.
6

m
g
/
k
g
1
2
-

2
4
T
a
b
2
.
5
,

5
,

1
0
1
4
.
A
m
o
x
y
c
i
l
l
i
n

(
R
)
I
N
,

C
H
P
O
2
0
-
4
0
8
D
r
o
p
s
1
0
0
O
r
a
l

a
b
s
o
r
p
t
i
o
n

b
e
t
t
e
r

t
h
a
n
I
V
4
0
-
8
0
8
S
u
s
p
1
2
5
,

2
5
0
a
m
p
i
c
i
l
l
i
n
(
1
5
-
3
0

m
i
n
)
C
a
p
2
5
0
,

5
0
0
D
i
s
t
a
b
1
2
5
,

2
5
0
V
i
a
l
1
0
0
,

2
5
0
,

5
0
0

1
5
.
A
m
o
x
y
c
i
l
l
i
n

+
N
B
,

I
N
,

C
H
P
O
A
m
o
x

3
0
-

5
0
8
T
a
b
s
/
S
u
s
p
.
A
m
o
x

2
5
0

+
G
I

d
i
s
t
u
r
b
a
n
c
e
s

m
o
r
e
c
l
a
v
u
l
a
n
i
c

a
c
i
d

(
R
)
I
V
A
m
o
x

5
0
-
1
0
0
8
c
l
a
v

1
2
5
;
f
r
e
q
u
e
n
t

t
h
a
n

w
i
t
h
2
0
0

+

2
8
.
8
a
m
o
x
y
c
i
l
l
i
n

a
l
o
n
e
V
i
a
l
A
m
o
x

1
0
0
0

+
c
l
a
v

2
0
0
1
6
.
A
m
p
h
o
t
e
r
i
c
i
n

B
N
B
,

I
N
,

C
H
I
V
T
e
s
t

d
o
s
e
:

0
.
1
O
D
V
i
a
l
5
0

m
g
D
i
l
u
e
n
t

5
%

d
e
x
t
r
o
s
e
,

s
t
r
e
n
g
t
h
(
R
,

H
)
O
v
e
r
m
g
/
k
g

f
o
l
l
o
w
e
d
o
f

d
i
l
u
t
e
d

s
o
l
u
t
i
o
n

=

0
.
1
m
g
/
m
L
.
4
-
6

h
r
b
y

0
.
2
5

m
g
/
k
g
/
N
o
t

t
o

b
e

m
i
x
e
d

w
i
t
h

o
t
h
e
r
d
a
y
.

I
n
c
r
e
a
s
e
s
o
l
u
t
i
o
n
s

o
r

d
r
u
g
s
.
g
r
a
d
u
a
l
l
y

t
o

1
m
g
/
k
g
/
d
a
y
.
1
7
.
A
m
p
i
c
i
l
l
i
n

(
R
)
S
e
p
t
i
c
e
m
i
a
N
B
,

I
N
,

C
H
I
V
1
0
0
-
2
0
0
4
S
y
r
/
S
u
s
p
1
2
5
,

2
5
0
F
o
o
d

i
n
t
e
r
f
e
r
e
s

w
i
t
h
M
e
n
i
n
g
i
t
i
s
N
B
,

I
N
,

C
H
I
V
2
0
0
-
4
0
0
4
-
6
V
i
a
l
1
0
0
,

2
5
0
,

5
0
0
,
a
b
s
o
r
p
t
i
o
n
.
1
0
0
0
1

g
m

A
m
p

=

3

m
E
q
N
a
O
t
h
e
r

i
n
f
e
c
t
i
o
n
s
N
B
,

I
N
,
C
H
P
O
5
0
-
1
0
0
4
-
6
D
r
o
p
1
0
0
1
8
.
A
m
i
n
o
c
a
p
r
o
i
c

a
c
i
d
C
H
I
V
1
0
0
-
2
0
0

m
g
/
k
g
6
V
i
a
l
















2
5
0

m
g
/
m
L
(
H
,

R
)
l
o
a
d
i
n
g
(
h
e
m
o
s
t
a
t
i
c

a
g
e
n
t
)
M
a
i
n
t
e
n
a
n
c
e
1
0
0

m
g
/
k
g
/
d
o
s
e
1
9
.
A
m
r
i
n
o
n
e
N
B
I
V
0
.
7
5

m
g
/
k
g

I
V
A
m
p
5
o
v
e
r

2
-
3

m
i
n
,
t
h
e
n

3
-
5

g
/
k
g
/
m
i
n
c
o
n
t
i
n
u
o
u
s

I
V
i
n
f
u
s
i
o
n
C
H
I
V
0
.
7
5

m
g
/
k
g
b
o
l
u
s
,

i
n
f
u
s
i
o
n
5
-
1
0

g
/
k
g
/
m
i
n
2
0
.
A
l
l
o
p
u
r
i
n
o
l

(
H
,

R
)
I
N
,

C
H
P
O
1
0
8
-
2
4
T
a
b
1
0
0
E
s
t
a
b
l
i
s
h

h
i
g
h

u
r
i
n
e

o
u
t
p
u
t
.
I
n
t
e
r
a
c
t
s

w
i
t
h

a
z
a
t
h
i
o
p
r
i
n
e
a
n
d

m
e
r
c
a
p
t
o
p
u
r
i
n
e
s
.
2
1
.
A
m
a
n
t
a
d
i
n
e

(
H
,

R
)
C
H
P
O
4
-
8
8
C
a
p
1
0
0
C
/
I

E
p
i
l
e
p
s
y
.
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
Principles of Pediatric and Neonatal Emergencies
748
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
2
2
.
A
m
p
i
c
i
l
l
i
n
I
N
,

C
H
I
V
,

I
M
A
m
p
i

1
0
0
6
V
i
a
l
s
A
m
p
i
c
i
l
l
i
n

1

g
E
f
f
e
c
t
i
v
e

a
g
a
i
n
s
t

+

S
u
l
b
a
c
t
a
m

(
H
,

R
)
S
u
l
b
a
c
t
a
m
L
a
c
t
a
m
a
s
e

p
r
o
d
u
c
i
n
g
0
.
5

g
o
r
g
a
n
i
s
m
s

t
o
o
.
2
3
.
A
n
t
i
h
e
m
o
p
h
i
l
i
c
I
V
D
o
s
e

(
U
)
I
n
j
2
0
0

U
,

2
5
0

U
,
f
a
c
t
o
r
,

h
u
m
a
n
W
t

(
k
g
)

x

0
.
5

x
5
0
0

U
,

7
5
0

U
,
d
e
s
i
r
e
d

i
n
c
r
e
a
s
e
1
0
0
0

U
,
i
n

f
a
c
t
o
r

V
I
I
I
1
5
0
0

U
(
%

o
f

n
o
r
m
a
l
)
2
4
.
A
n
t
i
-
R
h
R
h
-
v
e

m
o
t
h
e
r
I
M
2
5
0
-
3
0
0

g
V
i
a
l
1
0
0
,

2
5
0
,

3
5
0

g
M
o
t
h
e
r

s
h
o
u
l
d

h
a
v
e

n
e
g
a
t
i
v
e
i
m
m
u
n
o
g
l
o
b
u
l
i
n
w
i
t
h

R
h
+
v
e
s
i
n
g
l
e

d
o
s
e
i
n
d
i
r
e
c
t

C
o
o
m
b
s

t
e
s
t

d
u
r
i
n
g
b
a
b
i
e
s
w
i
t
h
i
n

7
2

h
o
u
r
s
p
r
e
g
n
a
n
c
y
.
o
f

d
e
l
i
v
e
r
y

o
r
a
b
o
r
t
i
o
n
2
5
.
A
n
t
i
-
s
n
a
k
e

v
e
n
o
m
I
N
,

C
H
I
V
I
n
i
t
i
a
l

5
0

m
L
V
i
a
l
1
0

m
L
T
o

b
e

d
i
l
u
t
e
d

w
i
t
h

2
5
0

m
L

o
f
a
n
t
i
s
e
r
a

(
p
o
l
y
v
a
l
e
n
t
)
(
I
n
f
u
s
i
o
n
)
(
d
o
s
e

u
p

t
o
I
V

f
l
u
i
d
s

a
n
d

g
i
v
e
n

s
l
o
w
l
y

2
0
1
5
0
-
2
0
0

m
L
m
L
/
k
g
/
h
r
.

I
n

s
e
v
e
r
e

c
a
s
e
s
m
a
y

b
e

r
e
q
u
i
r
e
d
)
d
o
s
e
s

o
f

1
0
0
-
2
0
0

m
L

m
a
y

b
e
r
e
q
u
i
r
e
d
.

S
e
n
s
i
t
i
v
i
t
y

t
e
s
t

t
o
e
q
u
i
n
e

s
e
r
u
m

i
s

m
u
s
t
.
D
e
s
e
n
s
i
t
i
z
a
t
i
o
n

h
a
s

t
o

b
e
d
o
n
e

i
n

s
e
n
s
i
t
i
v
e

i
n
d
i
v
i
d
u
a
l
s
.
2
6
.
A
r
t
e
m
e
t
h
e
r
I
N
,

C
H
I
M
3
.
2

m
g
/
k
g

D
1
2
4

(
f
o
r

t
o
t
a
l
A
m
p
4
0
,

8
0
f
o
l
l
o
w
e
d

b
y

1
.
6
5

d
a
y
s
)
m
g
/
k
g
2
7
.
A
t
e
n
o
l
o
l

(
R
)
I
N
,

C
H
P
O
1
-
2
1
2
-
2
4
T
a
b
5
0
,
1
0
0
C
/
I
-
B
r
a
d
y
c
a
r
d
i
a
,

h
e
a
r
t

b
l
o
c
k
,
C
C
F
,

A
s
t
h
m
a
.
2
8
.
A
t
r
o
p
i
n
e
U
s
u
a
l

d
o
s
e
I
N
,

C
H
S
C
0
.
0
1

m
g
/
k
g
/
d
o
s
e

R
e
p
e
a
t

P
R
N
.
A
m
p
0
.
6
C
/
I
-
T
a
c
h
y
a
r
r
h
y
t
h
m
i
a
s
O
r
g
a
n
o
p
h
o
s
p
h
o
r
u
s
I
V
0
.
0
5

m
g
/
k
g
/
d
o
s
e

e
v
e
r
y
p
o
i
s
o
n
i
n
g
1
0
-
2
0

m
i
n

u
n
t
i
l

a
t
r
o
p
i
n
e
e
f
f
e
c
t
,

t
h
e
n

e
v
e
r
y

1
-
4

h
r
f
o
r

2
4

h
r
2
9
.
A
t
r
a
c
u
r
i
u
m

b
e
s
y
l
a
t
e
I
N
I
V
0
.
3
-
0
.
4
P
R
N
A
m
p
1
0
m
g
/
k
g
/
d
o
s
e
C
H
I
V
0
.
4
-
0
.
5
m
g
/
k
g
/
d
o
s
e
C
o
n
t
i
n
u
o
u
s
i
n
f
u
s
i
o
n
:

0
.
4
-
0
.
8
m
g
/
k
g
/
h
r
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
749 749 749 749 749
Dosages of Some Common Drugs
749
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
3
0
.
A
z
i
t
h
r
o
m
y
c
i
n

(
H
,

R
)
I
N
,

C
H
P
O
1
0

m
g
/

k
g

d
a
y

1
,
2
4
S
u
s
p
1
0
0
/

5

m
L
f
o
l
l
o
w
e
d

b
y

5
2
0
0
/

5

m
L
m
g
/
k
g

d
a
y

2
-

d
a
y
T
a
b
2
5
0
,

5
0
0
5
3
1
.
A
z
t
r
e
o
n
a
m

(
R
)
I
N
,

C
H
I
V
,

I
M
9
0
-
1
2
0
6
-

8
V
i
a
l
5
0
0
,

1
0
0
0
3
2
.
B
a
c
l
o
f
e
n

(
R
)
C
H
P
O
1
0
-
1
5

m
g
/

d
a
y
8
T
a
b
1
0
,

2
0
(
m
a
x

d
o
s
e
:

<

8
y
r
-

4
0

m
g
/
d
;

>
8
y
r
-

6
0

m
g
/

d
)
3
3
.
B
e
c
l
o
m
e
t
h
a
s
o
n
e
C
H
I
n
h
a
l
a
t
i
o
n
4
0
0
-
8
0
0

g
/
d
a
y
8
-
1
2
M
e
t
e
r
e
d

d
o
s
e
5
0
,
1
0
0
C
a
n

c
a
u
s
e

h
o
a
r
s
e
n
e
s
s
,

o
r
a
l
i
n
h
a
l
e
r
2
0
0

g

p
e
r
c
a
n
d
i
d
i
a
s
i
s

o
r

a
s
p
e
r
g
i
l
l
o
s
i
s
a
c
t
u
a
t
i
o
n
R
i
n
s
e

m
o
u
t
h

a
n
d

g
a
r
g
l
e

w
i
t
h
w
a
t
e
r

a
f
t
e
r

i
n
h
a
l
a
t
i
o
n
.
R
o
t
a
c
a
p
s
1
0
0
,

2
0
0

g
N
a
s
a
l

s
p
r
a
y
5
0
-
1
0
0

g
/
d
1
2
-
2
4
N
a
s
a
l

s
p
r
a
y
5
0

g
p
e
r

a
c
t
u
a
t
i
o
n
3
4
.
B
e
t
a
m
e
t
h
a
s
o
n
e
I
N
,

C
H
P
O
0
.
0
6
-
0
.
2
5
6
-
1
2
T
a
b
0
.
5
D
o
s
e

v
a
r
i
e
s

w
i
t
h

t
h
e

d
i
s
e
a
s
e
I
V
1
-
4

m
g

t
o
t
a
l
I
n
j
.
4
3
5
.
B
e
n
z
a
t
h
i
n
e

P
e
n
i
c
i
l
l
i
n
V
i
a
l
0
.
6
,

1
.
2
,

2
.
4
S
e
n
s
i
t
i
v
i
t
y

t
e
s
t

i
s

n
e
e
d
e
d
(
R
)
;

P
r
i
m
a
r
y
<

2
7

k
g
D
e
e
p

I
M
0
.
6

m
e
g
a
u
n
i
t
s
3
-
4

w
k
m
e
g
a
u
n
i
t
s
b
e
f
o
r
e

e
a
c
h

d
o
s
e
.
P
r
e
v
e
n
t
i
o
n
(
t
o
t
a
l
)
>

2
7

k
g
1
.
2

m
e
g
a
u
n
i
t
s
(
t
o
t
a
l
)
3
6
.
B
u
d
e
s
o
n
i
d
e
I
N
,

C
H
I
n
h
a
l
a
t
i
o
n
1
0
0
-
8
0
0

g
/
d
1
2
M
e
t
e
r
e
d

d
o
s
e
1
0
0

g
/
2
0
0

g
(
M
D
I
,
i
n
h
a
l
e
r
p
e
r

a
c
t
u
a
t
i
o
n
n
e
b
u
l
i
z
a
t
i
o
n
)
A
m
p
2
5
0

g
/
m
L
5
0
0

g
/
m
L
3
7
.
C
a
l
c
i
u
m

g
l
u
c
o
n
a
t
e
N
B
,

I
N
,

C
H
I
V
1
-
2

m
L
/
k
g

o
f

1
0
%
6
-
8
A
m
p
1
0
%

S
o
l
n
.
I
V

i
n
f
u
s
i
o
n

i
s

g
i
v
e
n

u
n
d
e
r
(
e
l
e
m
e
n
t
a
l

c
a
l
c
i
u
m
s
o
l
n
.

P
e
r

d
o
s
e
c
a
r
d
i
a
c

m
o
n
i
t
o
r
i
n
g
;

d
o

n
o
t
9
%
)
2
5
-
5
0

e
l
e
m
e
n
t
a
l
m
i
x

w
i
t
h

a
l
k
a
l
i

s
o
l
u
t
i
o
n
.
c
a
l
c
i
u
m
3
8
.
C
a
p
t
o
p
r
i
l

(
R
)
N
B
P
O
0
.
1
-
0
.
4

m
g
/
k
g
/
d
o
s
e
6
-
2
4
T
a
b
2
5
,

5
0
M
a
y

c
a
u
s
e

r
e
n
a
l

i
m
p
a
i
r
m
e
n
t
.
C
/
I
-
A
o
r
t
i
c

s
t
e
n
o
s
i
s
,

r
e
n
a
l
I
N
P
O
0
.
5
-
0
.
6
6
-
1
2
a
r
t
e
r
y

s
t
e
n
o
s
i
s
.

D
o
s
e

m
a
y

b
e
C
H
P
O
0
.
5
-
1
4
-
8
i
n
c
r
e
a
s
e
d

g
r
a
d
u
a
l
l
y

t
o

g
e
t
(
m
a
x

6

m
g
/

k
g
/
d
e
s
i
r
e
d

e
f
f
e
c
t
.
d
a
y
)
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
Principles of Pediatric and Neonatal Emergencies
750
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
3
9
.
C
a
r
b
a
m
a
z
e
p
i
n
e

(
H
,

R
)
I
N
,

C
H
P
O
S
t
i
m
u
l
a
t
e
s

h
e
p
a
t
i
c
I
n
i
t
i
a
l
1
0
8
-
1
2
T
a
b
1
0
0
,

2
0
0
,

4
0
0
m
i
c
r
o
s
o
m
a
l

e
n
z
y
m
e
s
.

D
o
s
a
g
e
M
a
i
n
t
e
n
a
n
c
e
3
0
-
4
0
8
-
1
2
o
f

o
t
h
e
r

d
r
u
g
s

s
u
c
h

a
s
S
y
r
1
0
0
p
h
e
n
o
b
a
r
b
i
t
o
n
e
,

v
a
l
p
r
o
i
c

a
c
i
d
,
p
h
e
n
y
t
o
i
n

s
h
o
u
l
d

b
e

a
d
j
u
s
t
e
d
,
i
f

g
i
v
e
n

s
i
m
u
l
t
a
n
e
o
u
s
l
y
.

I
N
H
i
n
h
i
b
i
t
s

m
e
t
a
b
o
l
i
s
m
.
D
i
s
c
o
n
t
i
n
u
e

i
f

e
v
i
d
e
n
c
e

o
f
b
o
n
e

m
a
r
r
o
w

d
e
p
r
e
s
s
i
o
n
.
4
0
.
C
a
s
p
o
f
u
n
g
i
n

(
H
)
C
H
I
V
5
0

m
g
/

m
2
/
d
o
s
e
;
2
4
V
i
a
l
5
0
m
a
x

5
0

m
g
/

d
a
y
4
1
.
C
e
f
a
z
o
l
i
n

(
H
,

R
)
N
B
,

I
N
,

C
H
I
V

(
1
5
-
3
0

m
i
n
)
4
0
1
2
V
i
a
l
1
2
5
,

2
5
0
C
a
n

c
a
u
s
e

p
s
e
u
d
o
m
e
m
b
r
a
n
o
u
s
I
M
5
0
-
1
0
0
6
5
0
0
,

1
0
0
0
e
n
t
e
r
o
c
o
l
i
t
i
s
.

R
e
f
r
i
g
e
r
a
t
e
r
e
c
o
n
s
t
i
t
u
t
e
d

s
o
l
u
t
i
o
n
.
4
2
.
C
e
f
a
c
l
o
r

(
R
)
I
N
,

C
H
P
O
2
0
-
4
0
8
-
1
2
S
y
r
1
2
5
,

1
8
7
A
b
s
o
r
p
t
i
o
n

u
n
a
f
f
e
c
t
e
d

b
y
C
a
p
2
5
0
f
o
o
d

i
n
t
a
k
e
4
3
.
C
e
f
e
p
i
m
e

(
R
)
N
B
,

I
N
,

C
H
I
V
<

1
4

d
a
y
s

a
g
e
:

6
0
1
2
V
i
a
l
5
0
0
,

1
0
0
0
,
I
n

s
e
r
i
o
u
s

i
n
f
e
c
t
i
o
n
s
,
>
1
4

d
a
y
s

a
g
e
:
1
0
0
2
0
0
0
m
e
n
i
n
g
i
t
i
s

a
n
d

n
e
u
t
r
o
p
e
n
i
a
,
d
o
s
e

o
f

1
5
0

m
g
/

k
g
/
d
a
y

c
a
n
b
e

g
i
v
e
n

i
n

3

d
i
v
i
d
e
d

d
o
s
e
s
4
4
.
C
e
f
i
x
i
m
e

(
R
)
I
N
,

C
H
P
O
8
1
2
S
u
s
p
5
0
,

1
0
0
I
n

e
n
t
e
r
i
c

f
e
v
e
r
,

d
o
s
e

o
f

2
0
T
a
b
1
0
0
,

2
0
0
m
g
/
k
g
/
d
a
y

i
s

u
s
e
d
4
5
.
C
e
f
o
x
i
t
i
n

(
R
)
N
B
I
V
,

I
M
1
0
0
1
2
V
i
a
l
1
,

2
g
I
N
,

C
H
I
V
,

I
M
8
0
-
1
6
0
4
-
6
4
6
.
C
e
f
o
p
e
r
a
z
o
n
e

(
H
)
N
B
,

I
N
,

C
H
I
V
1
0
0
-
1
5
0
8
-
1
2
V
i
a
l
2
5
0
,

5
0
0
,

1
0
0
0
N
o
t

r
e
c
o
m
m
e
n
d
e
d

i
n
m
e
n
i
n
g
i
t
i
s
4
7
.
C
e
f
o
p
e
r
a
z
o
n
e

+
I
N
,

C
H
I
V
1
0
0
-
1
5
0

m
g
/
k
g
/
d
8
-
1
2
V
i
a
l
1

g

=

5
0
0

m
g
s
u
l
b
a
c
t
a
m

(
1
:

1
)
o
f

c
e
f
o
p
r
a
z
o
n
e
e
a
c
h

o
f
c
e
f
o
p
e
r
a
z
o
n
e
a
n
d

s
u
l
b
a
c
t
a
m
4
8
.
C
e
f
p
o
d
o
x
i
m
e

(
R
)
I
N
,

C
H
P
O
1
0
1
2
S
u
s
p
5
0
,

1
0
0
T
a
b
1
0
0
,

2
0
0
4
9
.
C
e
f
u
r
o
x
i
m
e

(
R
)
I
N
,

C
H
P
O
2
5
0

t
o
t
a
l

d
o
s
e
1
2
U
T
I
N
B
I
V
1
0
0
1
2
M
e
n
i
n
g
i
t
i
s
I
N
,

C
H
I
V
2
0
0
-
2
4
0
6
-
8
V
i
a
l
2
5
0
,

7
5
0
N
B
I
V
,

I
M
3
0
-
1
0
0
8
-
1
2
T
a
b
1
2
5
,

2
5
0
O
t
h
e
r

i
n
f
e
c
t
i
o
n
s
I
N
,

C
H
I
V
,

I
M
5
0
-
1
0
0
6
-
8
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
751 751 751 751 751
Dosages of Some Common Drugs
751
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
5
0
.
C
e
f
o
t
a
x
i
m
e

(
R
)
E
x
c
e
l
l
e
n
t

C
S
F

p
e
n
t
r
a
t
i
o
n
;
O
t
h
e
r

i
n
f
e
c
t
i
o
n
s
N
B

<

7

d
a
y
s
I
V
,

I
M
1
0
0
1
2
V
i
a
l
2
5
0
,

1
0
0
0
i
n
e
f
f
e
c
t
i
v
e

a
g
a
i
n
s
t
>

7

d
a
y
s
I
V
,

I
M
1
5
0
8
e
n
t
e
r
o
c
o
c
c
i

a
n
d

l
i
s
t
e
r
i
a
.
I
N
,

C
H
I
V
,

I
M
1
0
0
-
2
0
0
6
-
8
C
o
n
t
a
i
n
s

2
.
2
m
E
q

N
a
/
g

o
f

s
a
l
t
.
B
a
c
t
e
r
i
a
l

M
e
n
i
n
g
i
t
i
s
I
N
,

C
H
I
V
2
0
0
6
5
1
.
C
e
f
t
a
z
i
d
i
m
e

(
R
)
N
B
I
V
S
e
e

n
e
w
b
o
r
n
V
i
a
l
2
5
0
,

5
0
0
,

1
0
0
0
P
o
s
s
e
s
s
e
s

a
n
t
i
-
p
s
e
u
d
o
m
o
n
a
l
t
a
b
l
e
a
c
t
i
v
i
t
y

E
x
c
e
l
l
e
n
t

C
S
F
M
e
n
i
n
g
i
t
i
s
I
N
,

C
H
1
5
0
8
P
e
n
e
t
r
a
t
i
o
n
.
O
t
h
e
r

i
n
f
e
c
t
i
o
n
s
I
N
,

C
H
1
0
0
-
1
5
0
8
5
2
.
C
e
f
t
i
z
o
x
i
m
e

(
R
)
I
N

(
>

3

m
o
)
I
V
3
0
-
6
0
8
-
1
2
V
i
a
l
5
0
0
,

1
0
0
0
R
e
f
r
i
g
e
r
a
t
e

r
e
c
o
n
s
t
i
t
u
t
e
d

s
o
l
n
.
M
o
r
e

e
f
f
e
c
t
i
v
e

a
g
a
i
n
s
t

g
r
a
m
S
e
v
e
r
e

i
n
f
e
c
t
i
o
n
s
I
N
,

C
H
1
0
0
-
1
5
0
8
-
1
2
p
o
s
i
t
i
v
e

o
r
g
a
n
i
s
m
s
.
5
3
.
C
e
f
t
r
i
a
x
o
n
e

(
H
)
N
B
,

I
N
,

C
H
I
M
,

I
V
5
0
-
1
0
0
1
2
V
i
a
l
2
5
0
,

5
0
0
,

1
0
0
0
M
a
y

c
a
u
s
e
P
s
e
u
d
o
m
e
m
b
r
a
n
o
u
s

c
o
l
i
t
i
s
.
M
e
n
i
n
g
i
t
i
s
8
0
-
1
0
0
1
2
A
m
p
,

c
o
n
t
a
i
n
i
n
g

1
%
T
y
p
h
o
i
d
7
5
1
2
l
i
g
n
o
c
a
i
n
e

i
s

p
r
o
v
i
d
e
d

w
i
t
h
I
M

p
r
e
p
a
r
a
t
i
o
n
s
.

D
i
s
p
l
a
c
e
s
b
i
l
l
i
r
u
b
i
n

f
r
o
m

a
l
b
u
m
i
n
b
i
n
d
i
n
g

s
i
t
e
s
.
5
4
.
C
h
l
o
r
a
m
p
h
e
n
i
c
o
l
N
B
S
e
e
S
y
r
/
S
u
s
p
1
2
5
N
e
w
b
o
r
n
s

m
a
y

d
e
v
e
l
o
p
(
R
,

H
)
n
e
w
b
o
r
n
g
r
a
y

b
a
b
y

s
y
n
d
r
o
m
e
c
h
a
r
t
C
a
p
2
5
0
,

5
0
0
I
N
,

C
H
P
O
,

I
V
5
0
-
1
0
0
6
V
i
a
l
5
0
0
,

1
0
0
0
(
1
5
-
3
0

m
i
n
s
)
5
5
.
C
h
l
o
r
o
q
u
i
n
e

(
R
)
C
H
P
O
(
P
C
)
1
0

m
g
/
k
g

(
b
a
s
e
)
T
a
b
1
5
0

m
g
R
e
p
e
a
t

t
r
e
a
t
m
e
n
t

i
f

v
o
m
i
t
i
n
g
T
h
e
r
a
p
e
u
t
i
c
s
t
a
t

f
o
l
l
o
w
e
d
b
a
s
e
o
c
c
u
r
s

w
i
t
h
i
n

3
0

m
i
n
s

o
f
b
y

5

m
g
/
k
g

a
f
t
e
r
S
y
r
5
0

m
g

b
a
s
e
g
i
v
i
n
g

d
r
u
g
s

p
e
r
s
i
s
t
e
n
t
6

h
o
u
r
s
,

t
h
e
n
A
m
p
.
4
0

m
g

b
a
s
e
v
o
m
i
t
i
n
g
,

s
e
v
e
r
e

i
l
l
n
e
s
s

c
a
l
l
s
5

m
g
/
k
g

O
D

x

2

d
a
y
s
f
o
r

p
a
r
e
n
t
e
r
a
l

t
h
e
r
a
p
y
.

I
V
I
M
,

I
V
5
m
g
/
k
g
(
b
a
s
e
)

p
e
r

d
o
s
e
p
r
e
p
a
r
a
t
i
o
n

c
a
n

b
e

d
i
l
u
t
e

w
i
t
h
1
2

h
r
l
y
1
0

m
L
/
k
g

o
f

i
s
o
t
o
n
i
c

s
a
l
i
n
e
P
r
o
p
h
y
l
a
x
i
s
P
O
5

m
g

b
a
s
e
/
k
g
/
w
e
e
k
l
y
a
n
d

i
n
f
u
s
e
d

o
v
e
r

3
-
4

h
r
s
.
5
6
.
C
h
l
o
r
p
r
o
m
a
z
i
n
e

(
H
)
I
N
,

C
H
P
O
2
4
-
6

P
R
N
T
a
b
1
0
,

2
5
,

5
0
O
v
e
r
d
o
s
e

m
a
y

p
r
o
d
u
c
e
1
0
0
P
a
r
k
i
n
s
o
n
i
a
n

s
y
n
d
r
o
m
e
.
I
M
2
2
4
S
y
r
5
,

2
5
S
l
o
w

I
V
1
-
2

m
g
/
k
g
/
d
o
s
e
2
-
4

h
r
l
y
A
m
p
.
2
5
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
Principles of Pediatric and Neonatal Emergencies
752
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
5
7
.
C
h
l
o
r
t
h
a
l
i
d
o
n
e
C
H
P
O
1
-
2
2
4
T
a
b
1
0
0
5
8
.
C
i
p
r
o
f
l
o
x
a
c
i
n
N
B
,

I
N
,

C
H
P
O
1
0
-
1
5
1
2
T
a
b
2
5
0
,

5
0
0
I
n
h
i
b
i
t
s

m
e
t
a
b
o
l
i
s
m

o
f
I
V
5
-
1
0
1
2
7
5
0
t
h
e
o
p
h
y
l
l
i
n
e
.
I
V

i
n
f
u
s
i
o
n
2
0
0

m
g
/
1
0
0

m
L
A
r
t
h
r
o
p
a
t
h
y

i
n

j
u
v
e
n
i
l
e
1
0
0

m
g
/
5
0

m
L
a
n
i
m
a
l
s
.
F
o
o
d
,

a
n
t
a
c
i
d
s

i
n
t
e
r
f
e
r
e

w
i
t
h
a
b
s
o
r
p
t
i
o
n
.
5
9
.
C
i
s
a
p
r
i
d
e
I
N
,

C
H
P
O
0
.
5
-
1
6
-
8
S
u
s
p
5
C
/
I
-
G
I

h
e
m
o
r
r
h
a
g
e
,

i
n
t
e
s
t
i
n
a
l
p
e
r
f
o
r
a
t
i
o
n
.
<

3
4

w
k
s

G
A
6
0
.
C
l
a
r
i
t
h
r
o
m
y
c
i
n

(
R
)
C
H
P
O
1
5
1
2
S
u
s
p
1
2
5
,

2
5
0
T
a
b
2
5
0
,

5
0
0
6
1
.
C
l
i
n
d
a
m
y
c
i
n

(
R
)
N
B
<
7

d
a
y
s
P
O
1
0
-
1
5
1
2
C
a
p
7
5
,

1
0
0
,

1
5
0
P
s
e
u
d
o
m
e
m
b
r
a
n
o
u
s
>

7

d
a
y
s
1
5
-
2
0
6
-
8
A
m
p
1
5
0
e
n
t
e
r
o
c
o
l
i
t
i
s
.
I
N
,

C
H
P
O
2
0
-
4
0
6
-
8
6
2
.
C
l
o
f
a
z
i
m
i
n
e

(
H
,
R
)
C
a
p
5
0
T
u
r
n
s

b
o
d
y

s
e
c
r
e
t
i
o
n
s

a
n
d
L
e
p
r
o
s
y
C
H
P
O
1
-
2
O
D
1
0
0
e
x
c
r
e
t
a

r
e
d
,

b
r
o
w
n
i
s
h

b
l
a
c
k
L
e
p
r
a

r
e
a
c
t
i
o
n
P
O
1
0
0

m
g
/
d
o
s
e
T
w
i
c
e

o
r
t
h
r
i
c
e
d
a
i
l
y

f
o
r
2
1

d
a
y
s
6
3
.
C
l
o
n
a
z
e
p
a
m

(
R
)
C
H
P
O
S
t
a
r
t

0
.
0
1
-
0
.
0
5
1
2
T
a
b
0
.
5
-

2
C
o
n
c
o
m
i
t
a
n
t

u
s
e

o
f

v
a
l
p
r
o
i
c

.
I
n
c
r
e
a
s
e

t
o

>
0
.
3
a
c
i
d

m
a
y

p
r
o
d
u
c
e

p
e
t
i
t
m
a
l
m
g
/
k
g
/
d
s
t
a
t
u
s
6
4
.
C
l
o
n
i
d
i
n
e
C
H
P
O
5
-
1
0

g
/

k
g
/
d
a
y
;
8
-
1
2
T
a
b
1
0
0
,

2
0
0

g
c
a
n

b
e

i
n
c
r
e
a
s
e
d
g
r
a
d
u
a
l
l
y

t
o

2
5

g
/

k
g
/
d
a
y

i
n

4
d
i
v
i
d
e
d

d
o
s
e
s
6
5
.
C
l
o
x
a
c
i
l
l
i
n

(
R
)
I
N
,

C
H
P
O
5
0
-

1
0
0
6
S
y
r
1
2
5
I
n
j

s
t
a
b
l
e

a
t

r
o
o
m

t
e
m
p
e
r
a
t
u
r
e
I
V
1
0
0
-

2
0
0
6
C
a
p
2
5
0
,

5
0
0
f
o
r

3

d
a
y
s
.
V
i
a
l
2
5
0
,

5
0
0
1
0
0
0
6
6
.
C
o
d
e
i
n
e

p
h
o
s
p
h
a
t
e
(
H
,

R
)
A
n
t
i
t
u
s
s
i
v
e
I
N
,

C
H
P
O
1
-
1
.
5
4

P
R
N
S
y
r
1
0
A
v
o
i
d

u
s
e

i
n

n
e
o
n
a
t
e
s
A
n
a
l
g
e
s
i
c
I
N
,

C
H
P
O
4
4
-
6

P
R
N
T
a
b
1
5
,

3
0
,

6
0
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
753 753 753 753 753
Dosages of Some Common Drugs
753
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
6
7
.
C
y
c
l
o
s
p
o
r
i
n

(
R
,

H
)
I
N
,

C
H
P
O
1
4
-
1
8

i
n
i
t
i
a
l
O
D
S
o
l
n
1
0
0
1
-
2

w
k
s

t
h
e
r
e
A
m
p
5
0
M
o
n
i
t
o
r

l
e
v
e
l
s

o
f

c
y
c
l
o
s
p
o
r
i
n
a
f
t
e
r

5
-
1
0
1
2
-
2
4
I
V
2
-
6
1
2
-
2
4
(
2
-
6

h
r
s
)
6
8
.
D
e
f
e
r
o
x
a
m
i
n
e

(
R
)
C
H
S
C
5
0

m
g
/
k
g
/
t
o
t
a
l
V
i
a
l
5
0
0

m
g
C
/
I
:

A
R
F

u
n
l
e
s
s

h
e
m
o
d
i
a
l
y
s
i
s
A
c
u
t
e

i
r
o
n
o
v
e
r

6
-
8

h
r
s
i
s

d
o
n
e

s
i
m
u
l
t
a
n
e
o
u
s
l
y
i
n
t
o
x
i
c
a
t
i
o
n
C
H
I
V
1
5

m
g
/
k
g
/
h
r
(
m
a
x

6

g
/
d
a
y
)
6
9
.
D
e
o
x
y
c
o
r
t
i
c
o
s
t
e
r
o
n
e
I
N
,

C
H
I
M
1
-
5

m
g
/
d
o
s
e
O
D
I
n
j
5
a
c
e
t
a
t
e

(
D
O
C
A
)
7
0
.
D
e
s
m
o
p
r
e
s
s
i
n
I
N

(
>

3

m
o
)
I
n
t
r
a
n
a
s
a
l
1
0
-
2
0

g

t
o
t
a
l
1
2
-
2
4
S
o
l
n
1
0

g
/
A
v
o
i
d

i
n

r
e
n
a
l

i
m
p
a
i
r
m
e
n
t
,
(
D
D
A
V
P
)
C
H
m
e
t
e
r
e
d

s
p
r
a
y
h
y
p
e
r
t
e
n
s
i
o
n
I
n
j
4

g

/
m
l
7
1
.
D
e
x
a
m
e
t
h
a
s
o
n
e
N
B
I
V
0
.
2
5

m
g
/
k
g
/
d
o
s
e
1
2

h
r

(
3
-
4

d
o
s
e
)
T
a
b
0
.
5

m
g
A
i
r
w
a
y
V
i
a
l
8

m
g
,

1
0
0

m
g
e
d
e
m
a
/
e
x
t
u
b
a
t
i
o
n
C
H
I
V
0
.
5
-
2

m
g
/
k
g
/
d
a
y
6

h
r

(
4
-
6
(
s
t
a
r
t

1
2
-
2
4

h
r
d
o
s
e

a
f
t
e
r
b
e
f
o
r
e

e
x
t
u
b
a
t
i
o
n
)
e
x
t
u
b
a
t
i
o
n
)
B
a
c
t
e
r
i
a
l

m
e
n
i
n
g
i
t
i
s
I
N
,

C
H
I
V
0
.
6

m
g
/
k
g
/
d
6

h
r

(
4

d
a
y
s
)
C
e
r
e
b
r
a
l

e
d
e
m
a
I
N
,

C
H
I
V
1
-
2

m
g
/
k
g
l
o
a
d
i
n
g
;
1
-
1
.
5

m
g
/
k
g
/
d
4
-
6

h
r
7
2
.
D
e
x
t
r
a
n
C
H
I
V
2
0

m
L
/
k
g

i
n
f
u
s
i
o
n
D
e
x
t
r
a
n

4
0
P
l
a
s
m
a

v
o
l
u
m
e

e
x
p
a
n
d
e
r
o
v
e
r

1
-
2

h
r
s
D
e
x
t
r
a
n

7
0
7
3
.
D
i
a
z
e
p
a
m

(
H
,

R
)
N
B
I
V
,

P
O
0
.
1
-
0
.
3

m
g
/
k
g
/
d
o
s
e
T
a
b
2
.
5
I
V

g
i
v
e
n

s
l
o
w
l
y

(
<

1

m
g
/
m
i
n
)
I
N
,

C
H
I
V
,

P
O
0
.
1
-
0
.
5

m
g
/
k
g
/
d
o
s
e
S
y
r
2
u
n
d
i
l
u
t
e
d
;

h
i
g
h
e
r

d
o
s
e
s

f
o
r
P
R
0
.
3
-
0
.
5

m
g
/
k
g
/
d
o
s
e
A
m
p
5
t
e
t
a
n
u
s

n
e
o
n
a
t
o
r
u
m
.
7
4
.
D
i
a
z
o
x
i
d
e

(
R
)
C
H
I
V
2
-
5

m
g
/
k
g
/
d
o
s
e
B
o
l
u
s
A
m
p
1
5
R
e
p
e
a
t

a
f
t
e
r

h
o
u
r

i
f
H
y
p
e
r
t
e
n
s
i
o
n
n
e
c
e
s
s
a
r
y
.
H
y
p
e
r
i
n
s
u
l
i
n
e
m
i
c
P
O
8
-
1
5
8
-
1
2
S
y
r
5
0
S
w
i
t
c
h

t
o

o
r
a
l

m
e
d
i
c
a
t
i
o
n

a
s
h
y
p
o
g
l
y
c
e
m
i
a
e
a
r
l
y

a
s

p
o
s
s
i
b
l
e
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
Principles of Pediatric and Neonatal Emergencies
754
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
7
5
.
D
i
c
y
c
l
o
m
i
n
e

(
R
,
H
)
N
B
P
O
2
.
5
-
5

m
g
/
d
o
s
e
6
-
8
D
r
o
p
s
1
0
t
o
t
a
l
S
u
s
p
1
0
I
N
,

C
H
P
O
5
-
1
0

m
g
/
d
o
s
e
6
-
8
T
a
b
2
0
I
n
j
1
0
7
6
.
D
i
g
o
x
i
n

(
R
)
H
a
l
f

o
f

d
i
g
i
t
a
l
i
z
i
n
g

d
o
s
e

i
s
D
i
g
i
t
a
l
i
z
i
n
g

d
o
s
e
P
r
e
m
a
t
u
r
e
I
V
0
.
0
1
5
-
0
.
0
2
5
E
l
i
x
i
r
0
.
2
5
g
i
v
e
n

a
s

l
o
a
d
i
n
g

f
o
l
l
o
w
e
d

b
y
(
m
g
/
k
g
)
N
B
,

C
H
I
M
,

I
V
0
.
0
1
-
0
.
0
3
T
a
b
0
.
2
5

a
f
t
e
r

8

h
o
u
r
s

a
n
d

r
e
s
t

P
O
0
.
0
4
A
m
p
0
.
2
5
a
f
t
e
r

a
n
o
t
h
e
r

8

h
o
u
r
s
.
I
N
I
M
,

I
V
0
.
0
3
-
0
.
0
4
M
a
i
n
t
e
n
a
n
c
e

b
e
g
i
n
s

2
4

h
r
P
O
0
.
0
5
a
f
t
e
r

t
h
e

d
i
g
i
t
i
a
l
i
z
i
n
g

d
o
s
e
T
o
x
i
c
i
t
y

i
n
c
r
e
a
s
e
s

b
y

c
a
l
c
i
u
m
M
a
i
n
t
e
n
a
n
c
e
N
B
P
O
0
.
0
5
-
0
.
0
1
1
2
-
2
4
c
h
a
n
n
e
l

b
l
o
c
k
e
r
s
.

I
V

c
a
l
c
i
u
m
I
N
,

C
H
P
O
0
.
0
1
5
s
h
o
u
l
d

b
e

g
i
v
e
n

t
o

d
i
g
i
t
a
l
i
z
e
d
p
a
t
i
e
n
t
s
.
C
/
I
:

v
e
n
t
r
i
c
u
l
a
r

t
a
c
h
y
c
a
r
d
i
a
a
n
d

v
e
n
t
r
i
c
u
l
a
r

p
r
e
m
a
t
u
r
e
b
e
a
t
s
.
7
7
.
D
i
m
e
r
c
a
p
r
o
l

(
B
A
L
)
I
N
,

C
H
I
M
1
2
-
2
4
4
A
m
p
5
0
A
n
t
i
d
o
t
e

f
o
r

A
s
,

A
u
,

H
g

a
n
d

P
b
(
H
)

(
R
)
p
o
i
s
o
n
i
n
g
7
8
.
D
i
p
h
t
h
e
r
i
a

a
n
t
i
t
o
x
i
n
I
N
,

C
H
I
V
A
m
p
1
0
,
0
0
0

u
T
e
s
t

s
e
n
s
i
t
i
v
i
t
y

t
o

h
o
r
s
e
(
A
D
S
-
e
q
u
i
n
e
)
2
0
,
0
0
0

u
s
e
r
u
m
.

S
e
n
s
i
t
i
v
e

p
a
t
i
e
n
t
s
m
u
s
t

b
e

d
e
s
e
n
s
i
t
i
z
e
d
.
P
h
a
r
y
n
g
e
a
l

a
n
d
2
0
,
0
0
0
-
4
0
,
0
0
0

U
l
a
r
y
n
g
e
a
l
t
o
t
a
l

d
o
s
e
I
V

g
i
v
e
n

d
i
l
u
t
e
d

1
0
-
2
0

i
n
N
a
s
o
p
h
a
r
y
n
g
e
a
l
4
0
,
0
0
0
-
6
0
,
0
0
0

U
i
s
o
t
o
n
i
c

s
a
l
i
n
e
,

r
a
t
e

1

m
l
/
m
i
n
.
t
o
t
a
l

d
o
s
e
E
x
t
e
n
s
i
v
e

d
i
s
e
a
s
e
8
0
,
0
0
0
-
1
,
0
0
,
0
0
0
o
r

w
i
t
h

>

3

d
a
y
s
U

t
o
t
a
l

d
o
s
e
d
u
r
a
t
i
o
n
7
9
.
D
o
b
u
t
a
m
i
n
e
N
B
I
V
2
-
2
0

g
/
k
g
/
m
i
n
V
i
a
l
2
5
0

m
g
N
o
t

t
o

b
e

m
i
x
e
d

w
i
t
h
I
N
,
C
H
(
C
o
n
s
t
a
n
t
5
-
2
0

g
/
k
g
/
m
i
n
N
a
H
C
O
3
i
n
f
u
s
i
o
n
)
8
0
.
D
o
m
p
e
r
i
d
o
n
e
I
N
,

C
H
P
O
0
.
6
-
1
.
2
8
T
a
b
1
0
E
x
t
r
a
p
y
r
a
m
i
d
a
l

r
e
a
c
t
i
o
n
s

l
e
s
s
D
r
o
p
s
1
t
h
a
n

m
e
t
o
c
l
o
p
r
a
m
i
d
e
S
u
s
p
5
8
1
.
D
o
p
a
m
i
n
e
N
B
I
V
2
.
5
-
2
0

g
/
k
g
/
m
i
n
A
m
p

5

m
L
4
0

m
g
/
m
L
C
/
I

o
b
s
t
r
u
c
t
i
v
e
I
N
,
C
H
C
o
n
s
t
a
n
t
2
.
5
-
4
0

m
g
/
k
g
/
m
i
n
c
a
r
d
i
o
m
y
o
p
a
t
h
y
.

N
o
t

t
o

b
e
i
n
f
u
s
i
o
n
m
i
x
e
d

w
i
t
h

s
o
d
i
u
m
b
i
c
a
r
b
o
n
a
t
e
.
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
755 755 755 755 755
Dosages of Some Common Drugs
755
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
8
2
.
D
o
x
a
p
r
a
m

H
C
l
N
B
I
V
S
t
a
r
t

w
i
t
h

0
.
5
A
m
p
2
0

m
g
/
m
L
C
o
n
s
t
a
n
t

i
n
f
u
s
i
o
n

f
o
r

a
p
n
e
a
m
g
/
k
g
/
h
r

a
n
d
o
f

p
r
e
m
a
t
u
r
i
t
y

f
a
i
l
i
n
g

t
h
e
i
n
c
r
e
a
s
e

b
y

0
.
5
o
p
h
y
l
l
i
n
e

t
h
e
r
a
p
y
.

N
o
t

t
o
m
g
/
k
g
/
h
r

t
o

a
b
e

m
i
x
e
d

w
i
t
h

s
o
d
i
u
m
m
a
x
i
m
u
m

o
f

2
.
5
b
i
c
a
r
b
o
n
a
t
e
.
m
g
/
k
g
/
h
r
8
3
.
E
n
a
l
a
p
r
i
l

(
R
)
I
N
,

C
H
P
O
0
.
1
-

1
.
0
1
2
-

2
4
T
a
b
s
2
.
5
,

5
8
4
.
E
n
o
x
a
p
a
r
i
n

(
R
)
I
N
,

C
H
S
C
<

2

m
o
n
-

1
.
5

m
g
/
1
2
I
n
j
1
0
0

m
g
/

m
L
k
g
/

d
o
s
e
>

2

m
o
n
-

1
1
2
m
g
/
k
g
/
d
o
s
e
8
5
.
E
r
y
t
h
r
o
m
y
c
i
n

(
R
)
I
N
,

C
H
P
O
3
0
-
5
0
6
T
a
b
s
1
0
0
,
1
2
5
,
2
5
0
,
C
/
I
,

H
e
p
a
t
i
c

d
y
s
f
u
n
c
t
i
o
n

a
n
d
5
0
0
g
a
s
t
r
i
t
i
s
.
S
u
s
p
1
2
5
I
V
1
5
-
2
0
6
D
r
o
p
s
1
0
0
I
n
j
.
1

g
8
6
.
E
t
h
o
s
u
x
i
m
i
d
e

(
H
,

R
)
I
N
,

C
H
P
O
2
0
-
4
0
1
2
T
a
b
2
5
0
S
y
r
2
5
0
8
7
.
F
e
n
t
a
n
y
l

(
R
)
N
B
,

I
N
,

C
H
I
V
1
-
5

g
/
k
g
/
d
o
s
e
1
-
4

h
r
A
m
p
5
0

g
R
a
p
i
d

i
n
f
u
s
i
o
n

m
a
y

l
e
a
d

t
o
C
o
n
t
i
n
u
o
u
s
c
h
e
s
t

w
a
l
l

t
i
g
h
t
n
e
s
s
i
n
f
u
s
i
o
n
:
1
-
5

g
/
k
g
/
h
r
8
8
.
F
l
u
c
o
n
a
z
o
l
e

(
R
)
C
H
P
O
,
I
V
3
-
6
1
2
-
2
4
I
n
j
2

m
g
/
m
L
C
a
p
,

T
a
b
5
0
,

1
0
0
,

1
5
0
,

2
0
0
8
9
.
F
l
u
c
y
t
o
s
i
n
e

(
R
)
N
B
,
I
N
,
C
H
P
O
,
I
V
5
0
-
1
5
0
6
-
8
T
a
b
5
0
0
F
o
r

c
r
y
p
t
o
c
o
c
c
a
l

m
e
n
i
n
g
i
t
i
s
I
n
j
.
1
0

m
g
/
m
L
a
l
o
n
g

w
i
t
h

A
m
p
h
o
t
e
r
i
c
i
n

B
.
9
0
.
F
l
u
d
r
o
c
o
r
t
i
s
o
n
e
A
n
y

a
g
e
P
O
5

g
/
k
g
O
D
T
a
b
1
0
0

g
a
c
e
t
a
t
e

(
R
)
9
1
.
F
o
s
p
h
e
n
y
t
o
i
n

(
R
)
C
H
I
V
L
o
a
d
i
n
g

d
o
s
e

i
n
I
n
j
5
0

m
g

P
E

p
e
r
s
t
a
t
u
s

e
p
i
l
e
p
t
i
c
u
s
:
m
L
1
5
-
2
0

m
g
P
h
e
n
y
t
o
i
n
e
q
u
i
v
a
l
e
n
t

(
P
E
)
/
k
g
.
M
a
i
n
t
e
n
a
n
c
e

4
-

6
2
4
m
g

P
E
/

k
g
/

d
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
Principles of Pediatric and Neonatal Emergencies
756
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
9
2
.
F
l
u
t
i
c
a
s
o
n
e

(
H
)
I
N
,

C
H
I
n
h
a
l
a
t
i
o
n
1
0
0
-
5
0
0

g
/
d
1
2
M
D
I
5
0
,

1
2
5

g
a
c
t
u
a
t
i
o
n
9
3
.
F
o
r
m
o
t
e
r
o
l
I
N
,

C
H
I
n
h
a
l
a
t
i
o
n
2
4
-
4
8

g
/
d
1
2
-
2
4
M
D
I
1
2

g

p
e
r
a
c
t
u
a
t
i
o
n
9
4
.
G
a
n
c
i
c
l
o
v
i
r

(
R
)
I
V
N
B
1
2
1
2
V
i
a
l
5
0
0
I
N
,

C
H
I
n
d
u
c
t
i
o
n
:

1
0
1
2
M
a
i
n
t
e
n
a
n
c
e
:

5
2
4
9
5
.
G
e
n
t
a
m
i
c
i
n

(
R
)
N
B
I
V
,

I
M
S
e
e

N
e
w
b
o
r
n

t
a
b
l
e
6
-
8
A
m
p
4
0
I
N
,

C
H
I
V
,

I
M
5
-
7
.
5
P
e
d

A
m
p
1
0
(
3
0
-
6
0

m
i
n
)
9
6
.
G
l
y
c
e
r
o
l
I
N
,

C
H
P
O
0
.
5
-
1
g
/
k
g
/

d
o
s
e
6
B
o
t
t
l
e
s

o
f

3
0
0
1

g
/
m
L
m
L
9
7
.
H
e
p
a
r
i
n
N
B
,

I
N
,

C
H
S
C
,

I
V
1
0
0

U
/
k
g
/
d
o
s
e
6
V
i
a
l
1
0
0
0

U
/
5
m
L
A
d
j
u
s
t

d
o
s
e

t
o

m
a
i
n
t
a
i
n

P
T
1
5
-
3
5

U
/
k
g
/
h
r
C
o
n
t
i
n
u
o
u
s
5
0
0
0

U
/
5
m
L
b
e
t
w
e
e
n

2
-
3

t
i
m
e
s

n
o
r
m
a
l
.
i
n
f
u
s
i
o
n
9
8
.
H
e
p
a
t
i
t
i
s

B

s
p
e
c
i
f
i
c
N
B
,

I
N
,

C
H
I
M

(
D
e
e
p
)
0
.
5

m
L

w
i
t
h
i
n

1
2
A
m
p
0
.
5
,

1
,

5

m
L
A
d
v
i
s
e
d

a
t

t
h
e

t
i
m
e

o
f
G
l
o
b
u
l
i
n
h
r

o
f

b
i
r
t
h
e
x
p
o
s
u
r
e

t
o

i
n
f
e
c
t
e
d

b
l
o
o
d
0
.
0
6
-
0
.
1

m
L
/
k
g
a
n
d

i
n
f
a
n
t
s

o
f

H
B
s
A
g
+
v
e
s
i
n
g
l
e

d
o
s
e
m
o
t
h
e
r
s
.
9
9
.
H
u
m
a
n

n
o
r
m
a
l
A
d
m
i
n
i
s
t
r
a
t
i
o
n

o
f

l
i
v
e
i
m
m
u
n
o
g
l
u
b
u
l
i
n
v
a
c
c
i
n
e
s

s
h
o
u
l
d

b
e

d
e
l
a
y
e
d
P
r
i
m
a
r
y
N
B
,

I
N
,

C
H
I
V
0
.
2
-
0
.
6

m
L
/
k
g

o
n
c
e
V
i
a
l
1
0
%

a
n
d

1
6
.
5
%
f
o
r

6

w
e
e
k
s

f
o
l
l
o
w
i
n
g
I
m
m
u
n
o
d
e
f
i
c
i
e
n
c
y
e
v
e
r
y

3
-
4

w
k
s
.
i
m
m
u
n
o
g
l
o
b
u
l
i
n
a
d
m
i
n
i
s
t
r
a
t
i
o
n
A
t
t
e
n
u
a
t
i
o
n

o
f
I
M

(
D
e
e
p
)
0
.
3

m
L
/
k
g

s
t
a
t
m
e
a
s
l
e
s
w
i
t
h
i
n

6

d
a
y
s

o
f
e
x
p
o
s
u
r
e
H
e
p
a
t
i
t
i
s

A
0
.
0
2
-
0
.
0
4

m
L
/
k
g
s
t
a
t
.
1
0
0
.
H
u
m
a
n

r
a
b
i
e
s
I
N
,

C
H
I
M
,

L
o
c
a
l
2
0

U
/
k
g
V
i
a
l
1
5
0

U
/
m
L
P
o
s
t
-
e
x
p
o
s
u
r
e
;

A
s

m
u
c
h

a
s
s
p
e
c
i
f
i
c
p
o
s
s
i
b
l
e

i
s

i
n
f
i
l
t
r
a
t
e
d

l
o
c
a
l
l
y
i
m
m
u
n
o
g
l
o
b
u
l
i
n
a
n
d

t
h
e

r
e
s
t

i
s

g
i
v
e
n

I
M
,

i
f
p
a
t
i
e
n
t

p
r
e
s
e
n
t
s

w
i
t
h
i
n

2
4

h
o
u
r
s
o
f

b
i
t
e
.
T
o
t
a
l

d
o
s
e

g
i
v
e
n

I
M

i
f
c
a
s
e

p
r
e
s
e
n
t
s

w
i
t
h
i
n

1
-
7

d
a
y
s
.
R
a
b
i
e
s

v
a
c
c
i
n
a
t
i
o
n
a
d
m
i
n
i
s
t
e
r
e
d

s
i
m
u
l
t
a
n
e
o
u
s
l
y
a
t

d
i
f
f
e
r
e
n
t

s
i
t
e
s
.
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
757 757 757 757 757
Dosages of Some Common Drugs
757
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
1
0
1
.
H
y
d
r
a
l
a
z
i
n
e

(
R
)
C
H
P
O
1
-
3
,

5
6
T
a
b
2
5
,

5
0
C
/
I
-
P
o
r
p
h
y
r
i
a
I
V
,

I
M
0
.
1
5

m
g
/
k
g
/
d
o
s
e
A
m
p
2
0
R
e
p
e
a
t

I
M
/
I
V

d
o
s
e

e
v
e
r
y
3
0
-
9
0

m
i
n
s

t
i
l
l

d
e
s
i
r
e
d

i
s
o
b
t
a
i
n
e
d
.
1
0
2
.
H
y
o
s
c
i
n
e
C
H

(
6
-
1
2

y
e
a
r
s
)
P
O
1
0

m
g

t
o
t
a
l

d
o
s
e
8
T
a
b
1
0
I
n
t
e
s
t
i
n
a
l

a
n
d

b
i
l
i
a
r
y

c
o
l
i
c
b
u
t
y
l
b
r
o
m
i
d
e
I
M
,
I
V
1
0
-
2
0

m
g

b
o
l
u
s
A
m
p
2
0
1
0
3
.
I
b
u
p
r
o
f
e
n

(
R
)
C
H
P
O
2
0
-
4
0
4
-
6
T
a
b
2
0
0
,

4
0
0
A
v
o
i
d

a
s
p
i
r
i
n

s
i
m
u
l
t
a
n
e
o
u
s
l
y
;
J
R
A
P
O
3
0
-
7
0
4
-
6
S
u
s
p
1
0
0
g
i
v
e

w
i
t
h

f
o
o
d

o
r

m
i
l
k
.

C
/
I
-
H
y
p
e
r
s
e
n
s
i
t
i
v
i
t
y

t
o

N
S
A
I
D
s
.
1
0
4
.
I
m
i
p
e
n
e
m
/
c
i
l
a
s
t
a
t
i
n
I
N
,

C
H
I
V
6
0
-
1
0
0
6
V
i
a
l
5
0
0
,
1
0
0
0

m
g
I
M
o
f

i
m
i
p
e
n
e
m
1
0
5
.
I
n
d
o
m
e
t
h
a
c
i
n
A
n
t
i
-
i
n
f
l
a
m
m
a
t
o
r
y
C
H
P
O
1
-
3
6
-
8
C
a
p
2
5
,

5
0
C
/
I
-
P
e
p
t
i
c

u
l
c
e
r
,

G
I
N
e
p
h
r
o
g
e
n
i
c

d
i
a
b
e
t
e
s
V
i
a
l
1

m
g
h
e
m
o
r
r
h
a
g
e
I
n
s
i
p
i
d
u
s
C
H
P
O
3
-
5
8
D
o
s
e
s

o
f

I
V

p
r
e
p
a
r
a
t
i
o
n

n
o
t

t
o
C
l
o
s
u
r
e

o
f

d
u
c
t
u
s
N
B
I
V
0
.
2

m
g
/
k
g
8
b
e

d
i
l
u
t
e
d
.
s
t
a
r
t

i
r
r
e
s
p
e
c
t
i
v
e
o
f

a
g
e

a
l
l
o
w
e
d
b
y

0
.
1
-
0
.
2
1
0
6
.
I
n
s
u
l
i
n

(
P
l
a
i
n
)
I
V
0
.
1

U
/
k
g
V
i
a
l
4
0
,

8
0

U
L
o
w

d
o
s
e

r
e
g
i
m
e
n

f
o
r
D
K
A
0
.
1

U
/
k
g
/
h
r
d
i
a
b
e
t
i
c

k
e
t
o
a
c
i
d
o
s
i
s
i
n

h
a
l
f
n
o
r
m
a
l

s
a
l
i
n
e
c
o
n
t
i
n
u
o
u
s
i
n
f
u
s
i
o
n

t
i
l
l

b
l
o
o
d
s
u
g
a
r

c
o
m
e
s

d
o
w
n
t
o

3
0
0

m
g
/
d
L
1
0
7
.
I
p
r
a
t
r
o
p
i
u
m
I
N
,

C
H
I
n
h
a
l
a
t
i
o
n
M
D
I
5
0
-
1
0
0

g
/
d
6
-
1
2
M
D
I
2
0

g

p
e
r
a
c
t
u
a
t
i
o
n
N
e
b
u
l
i
z
a
t
i
o
n
2
5
0

5
0
0

g
4
-
6
N
e
b
u
l
i
z
a
t
i
o
n
2
5
0

g
/
m
L
p
e
r

d
o
s
e
s
o
l
u
t
i
o
n
1
0
8
.
K
a
n
a
m
y
c
i
n

(
R
)
N
B
I
M
,
I
V
S
e
e

n
e
w
b
o
r
n

t
a
b
l
e
V
i
a
l
5
0
0
,
1
0
0
0
A
v
o
i
d

u
s
i
n
g

w
i
t
h

o
t
h
e
r
n
e
p
h
r
o
t
o
x
i
c

d
r
u
g
s
.
I
N
,

C
H
I
M
,

I
V











6
-
1
5
















1
2
-
2
4
(
3
0

m
i
n
)
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
Principles of Pediatric and Neonatal Emergencies
758
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
1
0
9
.
K
e
t
a
m
i
n
e
I
N
,

C
H
I
V
0
.
5

m
g
-
2

m
g
/
k
g

V
i
a
l
1
0

m
g
/
m
L
I
n
c
r
e
a
s
e
s

r
e
s
p
i
r
a
t
o
r
y
s
t
a
t
s
e
c
r
e
t
i
o
n
s
;

A
d
m
i
n
i
s
t
e
r

a
t
r
o
p
i
n
e
5
0

m
g
/
m
L
0
.
0
1

m
g
/
k
g
3
-
7

m
g
/
k
g

s
t
a
t
S
u
p
p
l
e
m
e
n
t
a
l
d
o
s
e
s

1
/
3
r
d

o
f
i
n
i
t
i
a
l

d
o
s
e
1
1
0
.
L
a
b
e
t
a
l
o
l
I
V
0
.
2
-
2

m
g
/
k
g
/
h
r
C
o
n
t
i
n
u
o
u
s
T
a
b
5
0
,

1
0
0
C
/
I
-
A
s
t
h
m
a
,

C
H
F
,

H
e
a
r
t
H
y
p
e
r
t
e
n
s
i
v
e

c
r
i
s
i
s
i
n
f
u
s
i
o
n
A
m
p
5
b
l
o
c
k
P
O
5
-
1
0
1
2
1
1
1
.
L
a
c
t
u
l
o
s
e
<

2

y
e
a
r
s
P
O
2
.
5
-
1
0

m
L
/
d
a
y
6
-
8
S
y
r
1
0

g
/
1
5

m
L
F
o
r

h
e
p
a
t
i
c

e
n
c
e
p
h
a
l
o
p
a
t
h
y
,
>

2

y
e
a
r
s
4
0
-
9
0

m
L
/
d
a
y
6
-
8
t
i
t
r
a
t
e

d
o
s
e

t
o

p
r
o
d
u
c
e

2
-
3
l
o
o
s
e

s
t
o
o
l
s

p
e
r

d
a
y
.
1
1
2
.
L
i
g
n
o
c
a
i
n
e
V
i
a
l
2
%

s
o
l
n
D
o
s
e

m
a
y

b
e

r
e
p
e
a
t
e
d

e
v
e
r
y
h
y
d
r
o
c
h
l
o
r
i
d
e

(
H
)
1

m
L

=

2
1

m
g
5
-
1
0

m
i
n
.

E
C
G

m
o
n
i
t
o
r
i
n
g
n
e
c
e
s
s
a
r
y
.

M
o
s
t

u
s
e
f
u
l

i
n
L
o
a
d
i
n
g
N
B
,

I
N
,

C
H
I
V
1
-
2

m
g
/
k
g
c
o
n
t
r
o
l
l
i
n
g

l
i
f
e

t
h
r
e
a
t
e
n
i
n
g
(
2
-
4

m
i
n
s
)
a
r
r
h
y
t
h
m
i
a
s

e
s
p
.

t
h
o
s
e
M
a
i
n
t
e
n
a
n
c
e
I
V
2
0
-
5
0

g
/
k
g
/
m
i
n
C
o
n
t
i
n
u
o
u
s
a
s
s
o
c
i
a
t
e
d

w
i
t
h

d
i
g
i
t
a
l
i
s
.
i
n
f
u
s
i
o
n
1
1
3
.
L
i
n
e
z
o
l
i
d
N
B
,

I
N
,

C
H
I
V
<

7

d
a
y
s

a
g
e
:

2
0
1
2
I
V

i
n
f
u
s
i
o
n
6
0
0

m
g
P
r
o
t
e
c
t

i
n
f
u
s
i
o
n

f
r
o
m

l
i
g
h
t
>

7

d
a
y
s

a
g
e
:

3
0
8
3
0
0

m
L
1
1
4
.
L
o
r
a
z
e
p
a
m

(
R
)
N
B
,

I
N
,

C
H
I
V
0
.
0
5

m
g
/
k
g
T
a
b
1
,
2
M
a
y

b
e

r
e
p
e
a
t
e
d

a
f
t
e
r
d
o
s
e

s
t
a
t
1
5
-
2
0

m
i
n
s
.

f
o
r

2

d
o
s
e
s
.
P
O
0
.
0
5
-
0
.
1
6
A
m
p
2
1
1
5
.
L
y
t
i
c

c
o
c
k
t
a
i
l
P
e
t
h
i
d
i
n
e
I
M

(
d
e
e
p
)
2
,

<
5
0

m
g
S
i
n
g
l
e
M
a
y

c
a
u
s
e

s
u
d
d
e
n
P
r
o
m
e
t
h
a
z
i
n
e
1
,

<

2
5

m
g
d
o
s
e
h
y
p
o
t
e
n
s
i
o
n
.
C
h
l
o
r
p
r
o
m
a
z
i
n
e
1
,

<

2
5

m
g
1
1
6
.
M
a
g
n
e
s
i
u
m

s
u
l
f
a
t
e
5
0
%

s
o
l
u
t
i
o
n

p
r
e
f
e
r
a
b
l
e

f
o
r

I
M
(
R
)
a
n
d

1
%

s
o
l
u
t
i
o
n

f
o
r

I
V

u
s
e
.
C
a
t
h
a
r
t
i
c
C
H
P
O
2
5
0

m
g
/
k
g
/
d
o
s
e
A
m
p
1
%
,

1
0
%
1
%

s
o
l
u
t
i
o
n

c
o
n
t
a
i
n
s
H
y
p
o
m
a
g
n
e
s
e
m
i
a
I
N
,

C
H
I
M
1
0
0

m
g
/
k
g
/
d
o
s
e
4
-
6
2
0
%
,

5
0
%
1
0

m
g

m
a
g
n
e
s
i
u
m

/
m
L
I
V
1
0
0

m
g
/
k
g
(
0
.
0
8

m
E
q

m
a
g
n
e
s
i
u
m
/
m
l
)
s
l
o
w
l
y
/
d
o
s
e
A
s
t
h
m
a
C
H
I
V
5
0
-
1
0
0

m
g
/
k
g
/
d
o
s
e
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
759 759 759 759 759
Dosages of Some Common Drugs
759
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
1
1
7
.
M
a
n
n
i
t
o
l
B
o
t
t
l
e
s

(
2
0
%
)
2
5
0

m
L

a
n
d
C
/
I
-
a
c
t
i
v
e

i
n
t
r
a
c
r
a
n
i
a
l
C
e
r
e
b
r
a
l

e
d
e
m
a
I
N
,

C
H
I
V

(
3
0
-
6
0
(
1
-
2
.
5

g
/
k
g
/
d
o
s
e
)
6
-
8
5
0
0

m
L
b
l
e
e
d
i
n
g
,

p
u
l
m
o
n
a
r
y

e
d
e
m
a
.
m
i
n
s
.
)
2
0
%

S
o
l
u
t
i
o
n
1
1
8
.
M
e
p
h
e
n
t
e
r
m
i
n
e
I
V
0
.
4

m
g
/
k
g
/
d
o
s
e
I
n
d
i
c
a
t
i
o
n
s
-
h
y
p
o
t
e
n
s
i
o
n
(
s
l
o
w
)
b
o
l
u
s
V
i
a
l
1
5
,

3
0

m
g

b
a
s
e
f
o
l
l
o
w
i
n
g

s
u
r
g
e
r
y

o
r
a
n
e
s
t
h
e
s
i
a
.
C
/
I
-
H
y
p
o
v
o
l
e
m
i
c

s
h
o
c
k
1
1
9
.
6
-
M
e
r
c
a
p
t
o
p
u
r
i
n
e

(
R
)
I
N
,
C
H
P
O
2
.
5
O
D
T
a
b
5
0
R
e
d
u
c
e

d
o
s
e

t
o

1
/
3
-
1
/
4
V
i
a
l
s
1
,
2
,
4
,
6
a
l
l
o
p
u
r
i
n
o
l

i
s

g
i
v
e
n
c
o
n
c
u
r
r
e
n
t
l
y
.
1
2
0
.
M
e
r
o
p
e
n
e
m

(
R
)
N
B
,

I
N
,

C
H
I
V
6
0
-

1
2
0
8
V
i
a
l
1

g
1
2
1
.
M
e
t
h
y
l
e
n
e

b
l
u
e

(
R
)
I
V

(
5

m
i
n
)
1
-
2

m
g
/
k
g
/
d
o
s
e
A
m
p
1
%
T
r
e
a
t
m
e
n
t

o
f

s
y
m
p
t
o
m
a
t
i
c
m
e
t
h
e
m
o
g
l
o
b
i
n
e
m
i
a
.
1
2
2
.
M
e
t
h
y
l
d
o
p
a

(
R
)
C
H
P
O
1
0
-
4
0
8
-
1
2
T
a
b
2
5
0
C
/
I
-
H
e
p
a
t
i
c

d
y
s
f
u
n
c
t
i
o
n
,
p
h
e
o
c
h
r
o
m
o
c
y
t
o
m
a
,
d
e
p
r
e
s
s
i
o
n
1
2
3
.
M
e
t
h
y
l
p
r
e
d
n
i
s
o
l
o
n
e
P
O
1
-
2
6
-
8
T
a
b
2
,

4
,

1
6
F
r
e
q
u
e
n
c
y

o
f

b
o
l
u
s

d
o
s
e
I
V
2
0
-
3
0

m
g
/
k
g
I
n
j
5
0
0
,
1
0
0
0
d
e
p
e
n
d
s

o
n

c
l
i
n
i
c
a
l

c
o
n
d
i
t
i
o
n
.
(
3
0

m
i
n
)
1
2
4
.
M
e
t
o
c
l
o
p
r
a
m
i
d
e

(
R
)
N
B
P
O
0
.
1
-
0
.
3
8
T
a
b
1
0
D
y
s
t
o
n
i
c

r
e
a
c
t
i
o
n
s

m
a
y

o
c
c
u
r
.
C
h
e
m
o
t
h
e
r
a
p
y
-
I
N
,

C
H
P
O
,
I
M
0
.
4
-
0
.
5
6
S
y
r
5
A
n
t
i
d
o
t
e
-
d
i
p
h
e
n
h
y
d
r
a
m
i
n
e
i
n
d
u
c
e
d

e
m
e
s
i
s
I
V

(
5

m
i
n
)
2
-
3

m
g
/
k
g
/
d
o
s
e
A
m
p
5
1
2
5
.
M
e
t
o
l
a
z
o
n
e

(
H
,

R
)
C
H
P
O
0
.
2
-
0
.
4
1
2
-
2
4
T
a
b
s
0
.
5
,

5
1
2
6
.
M
e
t
o
p
r
o
l
o
l

(
H
)
C
H
P
O
1
-
5
1
2
T
a
b
5
0
,

1
0
0
S
e
l
e
c
t
i
v
e

b
e
t
a
-
b
l
o
c
k
e
r
.
H
y
p
e
r
c
y
a
n
o
t
i
c

s
p
e
l
l
I
V
0
.
1

m
g
/
k
g
/
d
o
s
e
I
n
j
1
C
/
I

C
H
F
,

h
e
a
r
t

b
l
o
c
k
.
1
2
7
.
M
e
t
r
o
n
i
d
a
z
o
l
e

(
H
,

R
)
A
m
e
b
i
a
s
i
s
C
H
P
O
3
0
-
5
0
8
S
u
s
p
1
0
0
,
2
0
0
T
h
e
r
a
p
y

f
o
r

5
-
7

d
a
y
s

i
n
T
r
i
c
h
o
m
o
n
i
a
s
i
s
C
H
P
O
1
5
8
T
a
b
2
0
0
,
4
0
0
g
i
a
r
d
i
a
s
i
s

a
n
d

t
r
i
c
h
o
m
o
n
i
a
s
i
s
G
i
a
r
d
i
a
s
i
s
N
B
,

I
N
,

C
H
I
V
1
5

m
g
/
k
g

s
t
a
t
8
I
n
j
.
5

m
g
/
m
L
a
n
d

1
0

d
a
y
s

i
n

a
m
e
b
i
a
s
i
s
.
(
1
0
0

m
L
)
A
n
a
e
r
o
b
i
c

i
n
f
e
c
t
i
o
n
N
B
,

I
N
,

C
H
I
V
1
5

m
g
/
k
g
/
s
t
a
t
8
t
h
e
n

2
0
-
4
0
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
Principles of Pediatric and Neonatal Emergencies
760
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
1
2
8
.
M
i
d
a
z
o
l
a
m

(
H
,

R
)
N
B
I
V
0
.
2
-
0
.
5

g
/
k
g
/
m
i
n
V
i
a
l
5

m
g
,

1
0

m
g
c
o
n
t
i
n
u
o
u
s
i
n
f
u
s
i
o
n

o
r
0
.
0
5
-
0
.
1
5

g
/
k
g
2
-
4

h
r
I
V
0
.
0
5
-
0
.
2

g
/
k
g
/
o
d
1
-
2

g
/
k
g
/
m
i
n

o
r
0
.
5
-
0
.
2

g
/
k
g
2
-
4

h
r
I
V
0
.
1
5

g
/
k
g

i
v
l
o
a
d
i
n
g
;

c
o
n
t
i
n
u
o
u
s
i
n
f
u
s
i
o
n

1
-
8

g
/
k
g
/
m
i
n
1
2
9
.
M
i
l
r
i
n
o
n
e

(
R
)
I
N
,
C
H
I
V
5
0

g
/
k
g

l
o
a
d
i
n
g
C
o
n
t
i
n
u
o
u
s
I
n
j
1

m
g
/

m
L
I
n

c
h
i
l
d
r
e
n

w
i
t
h

l
o
w
/
d
o
s
e
;

c
o
n
t
i
n
u
o
u
s
i
n
f
u
s
i
o
n
b
o
r
d
e
r
l
i
n
e

B
P
,

l
o
a
d
i
n
g

d
o
s
e
i
n
f
u
s
i
o
n
:

0
.
2
5
-
1
m
a
y

b
e

a
v
o
i
d
e
d

g
/
k
g
/
m
i
n
m
a
i
n
t
e
n
a
n
c
e
1
3
0
.
M
o
r
p
h
i
n
e

(
R
)
N
B
S
C
,

I
M
,

I
V
0
.
0
5
-
0
.
1
4
-
6
A
m
p
1
0
,

1
5
,

2
5
O
v
e
r
d
o
s
e

m
a
y

c
a
u
s
e
m
g
/
k
g
/
d
o
s
e
P
R
N
r
e
s
p
i
r
a
t
o
r
y

d
e
p
r
e
s
s
i
o
n
;
I
N
,

C
H
S
C
,

I
M
,

I
V
0
.
1
-
0
.
2
a
n
t
i
d
o
t
e
-
n
a
l
o
r
p
h
i
n
e
/
n
a
l
o
x
o
n
e
.
(
5

m
i
n
)
m
g
/
k
g
/
d
o
s
e
1
3
1
.
N
a
l
o
x
o
n
e

H
C
l
N
B
,

I
N
,

C
H
S
C
,

I
V
,

I
M
0
.
1

m
g
/
k
g
/
d
o
s
e
A
m
p
4
0
0

g
/
m
L
T
o

b
e

r
e
p
e
a
t
e
d

a
f
t
e
r

2
-
3

m
i
n
s
P
R
N

u
p

t
o

3

t
i
m
e
s
,

a
n
d
t
h
e
r
e
a
f
t
e
r

1
-
2

h
r

t
i
l
l

o
p
i
o
i
d
d
e
p
r
e
s
s
i
o
n

p
e
r
s
i
s
t
s
.

N
o
t

t
o

b
e
g
i
v
e
n

t
o

i
n
f
a
n
t
s

t
o

a
d
d
i
c
t
i
v
e
m
o
t
h
e
r
s
.
1
3
2
.
N
a
p
r
o
x
e
n

(
H
,

R
)
(
C
H

>

2

y
r
)
P
O
1
0
-
2
0
1
2
T
a
b
2
5
0
C
/
I
-
P
e
p
t
i
c

u
l
c
e
r

s
y
n
d
r
o
m
e
.
,
1
3
3
.
N
e
o
s
t
i
g
m
i
n
e

(
R
)
N
B
P
O
1

m
g
/
d
o
s
e
4
T
a
b
1
5
D
o
s
e

t
o

b
e

a
d
m
i
n
i
s
t
e
r
e
d
I
M
,

S
C
5
0
-
2
5
0

g
/
d
o
s
e
A
m
p
0
.
5
,

2
.
5
3
0

m
i
n

p
r
i
o
r

t
o

f
e
e
d
s

C
/
I
:
i
n
t
e
s
t
i
n
a
l

a
n
d

u
r
i
n
a
r
y
I
N
,

C
H
P
O
1
.
3

m
g
/
d
o
s
e
4
-
6
o
b
s
t
r
u
c
t
i
o
n
.
I
M
,

S
C
2
5
0
-
5
0
0

g
/
d
o
s
e
4
1
3
4
.
N
e
t
i
l
m
i
c
i
n

(
R
)
N
B
L
e
s
s

n
e
p
h
r
o
t
o
x
i
c

c
o
m
p
a
r
e
d
<

7

d
a
y
s
I
M
,

I
V
5
1
2
A
m
p
1
0
,

2
5
,

5
0
t
o

o
t
h
e
r

a
m
i
n
o
g
l
y
c
o
s
i
d
e
s
.
>

7

d
a
y
s
,
(
3
0
-
6
0
)
7
.
5
8
1
0
0
,
I
N
,

C
H
5
-
7
.
5
8
2
0
0
,
3
0
0
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
761 761 761 761 761
Dosages of Some Common Drugs
761
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
1
3
5
.
N
i
f
e
d
i
p
i
n
e
I
N
,

C
H
S
L
,

P
O
0
.
2
5
-
6
-
8
C
a
p
5
,

1
0
C
o
n
c
u
r
r
e
n
t

a
d
m
i
n
i
s
t
r
a
t
i
o
n
0
.
5

m
g
/
k
g
/
d
o
s
e
T
a
b
2
0
w
i
t
h

b
l
o
c
k
e
r
s

m
a
y

l
e
a
d

t
o
(
R
e
t
a
r
d
h
y
p
o
t
e
n
s
i
o
n
,

a
n
g
i
n
a

a
n
d
p
r
e
p
a
r
a
t
i
o
n
)
c
a
r
d
i
a
c

f
a
i
l
u
r
e
.
1
3
6
.
N
i
t
r
a
z
e
p
a
m
I
N
,

C
H
P
O
0
.
5
-
1
1
2
-
2
4
T
a
b
5
,

1
0
U
s
e
d

i
n

m
y
o
c
l
o
n
u
s
,
p
s
y
c
h
o
m
o
t
o
r

e
p
i
l
e
p
s
y
,
a
b
s
e
n
c
e

s
e
i
z
u
r
e
s

a
n
d
i
n
f
a
n
t
i
l
e

s
p
a
s
m
s
.
1
3
7
.
N
i
t
r
o
g
l
y
c
e
r
i
n
e

(
H
,

R
)
I
N
,

C
H
I
V
0
.
5
-
1
0

g
/
k
g
/
m
i
n
C
o
n
t
i
n
u
o
u
s
A
m
p
5
0

m
g
V
e
n
o
d
i
l
a
t
o
r
i
n
f
u
s
i
o
n
1
3
8
.
N
i
t
r
o
p
r
u
s
s
i
d
e

(
H
,

R
)
I
N
,

C
H
I
V
S
t
a
r
t

a
t

0
.
3
-
0
.
5
C
o
n
t
i
n
u
o
u
s
V
i
a
l
5
0

m
g
P
r
o
t
e
c
t

f
r
o
m

l
i
g
h
t

g
/
k
g
/
m
i
n
;

U
s
u
a
l
i
n
f
u
s
i
o
n
d
o
s
e

3
-
4

g
/
k
g
/
m
i
n
;

m
a
x
-
1
0

g
/
k
g
/
m
i
n
1
3
9
.
N
o
r
e
p
i
n
e
p
h
r
i
n
e
I
N
,

C
H
I
V
0
.
1
-
2

g
/
k
g
/
m
i
n
C
o
n
t
i
n
u
o
u
s
A
m
p
1

m
g
I
n
c
r
e
a
s
e

s
y
s
t
e
m
i
c

v
a
s
c
u
l
a
r
i
n
f
u
s
i
o
n
r
e
s
i
s
t
a
n
c
e
;

m
o
d
e
r
a
t
e
l
y
i
n
o
t
r
o
p
i
c
1
4
0
.
O
n
d
a
n
s
e
t
r
o
n

(
H
)
I
N
,

C
H
I
V
0
.
1
5

0
.
4
5

k
g
/
d
o
s
e
8
T
a
b
4

m
g
,

8

m
g
P
O
<
4

y
e
a
r
s

2

m
g
4
A
m
p
2

m
g
/
m
L
4
-
1
1

y
e
a
r
s

4

m
g
4
>
1
2

y
e
a
r
s

8

m
g
4
1
4
1
.
O
s
e
l
t
a
m
i
v
i
r

(
R
)
I
N
,

C
H
P
O
<

1
5

k
g

6
0

m
g
1
2
C
a
p
7
5

m
g
1
5
-
2
3

k
g

9
0

m
g
S
y
r
u
p
1
2

m
g
/

m
L
2
4
-
4
0

k
g

1
2
0

m
g
>
4
0

k
g

1
5
0

m
g
1
4
2
.
P
a
n
c
u
r
o
n
i
u
m

(
H
,

R
)
I
N
,

C
H
I
V
0
.
0
4
-
0
.
1
R
e
p
e
a
t
A
m
p
1

m
g
m
g
/
k
g
/
d
o
s
e
q

2
0
-
3
0
2

m
g
m
i
n
1
4
3
.
P
a
n
t
o
p
r
a
z
o
l
e
C
H
I
V
1
-

2
1
2
-

2
4
I
n
j
4
0

m
g
1
4
4
.
P
a
r
a
l
d
e
h
y
d
e
N
B
I
V
,

P
R
0
.
2

m
L
/
k
g
/
d
o
s
e
A
m
p
s
U
s
e

g
l
a
s
s

(
n
o
t

p
l
a
s
t
i
c
)
I
N
,

C
H
I
V
,

I
M
0
.
1
5

m
L
/
k
g
/
d
o
s
e
s
y
r
i
n
g
e
s
.

P
R

p
r
e
f
e
r
r
e
d

r
o
u
t
e
a
s

I
M

i
s

p
a
i
n
f
u
l

a
n
d

c
a
n
P
R
0
.
3

m
L
/
k
g
/
d
o
s
e
c
a
u
s
e

p
u
l
m
o
n
a
r
y

e
d
e
m
a

a
n
d
e
q
u
a
l
l
y

d
i
l
u
t
e
d
h
e
m
o
r
r
h
a
g
e
.
w
i
t
h

l
i
q
u
i
d
D
i
l
u
t
e

1
:
1
0
-
1
:
2
5

f
o
r

I
V

u
s
e
.
p
a
r
a
f
f
i
n
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
Principles of Pediatric and Neonatal Emergencies
762
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
1
4
5
.
P
e
n
i
c
i
l
l
i
n
,

b
e
n
z
y
l

(
R
)
I
n
f
e
c
t
i
o
n
s

o
t
h
e
r

t
h
a
n
N
B

<

2
0
0
0

g
I
M
,

I
V
5
0
,
0
0
0

U
1
2
V
i
a
l
5
,
0
0
,
0
0
0
S
o
d
i
u
m

p
o
t
a
s
s
i
u
m

c
o
n
t
e
n
t
m
e
n
i
n
g
i
t
i
s
N
B

>

2
0
0
0

g
I
M
,

I
V
7
5
,
0
0
0

U
1
2
1
0
,
0
0
,
0
0
0
1
.
6
8

m
E
q
/
1

m
i
l
l
i
o
n

u
n
i
t
s
.
I
N
,

C
H
I
M
,

I
V
2
5
,
0
0
0
4
-
6
2
0
,
0
0
,
0
0
0

5
0
,
0
0
0

U
M
e
n
i
n
g
i
t
i
s
N
B

<

2
0
0
0

g
1
,
0
0
,
0
0
0

U
1
2
>

2
0
0
0

g
1
,
5
0
,
0
0
0
8

2
,
0
0
,
0
0
0

U
I
N
,

C
H
2
,
0
0
,
0
0
0

4
-
6
4
,
0
0
,
0
0
0

U
1
4
6
.
P
e
n
i
c
i
l
l
i
n
N
B
I
M
5
0
,
0
0
0

U
O
D
V
i
a
l
4
,
0
0
,
0
0
0

U
P
r
o
c
a
i
n
e

(
R
)
I
N
,

C
H
I
M
2
5
0
0
0
-
O
D
5
0
,
0
0
0

U
1
4
7
.
P
e
n
t
a
z
o
c
i
n
e
C
H
P
O
,
I
M
,
I
V
0
.
5
-
1
4
T
a
b
,

I
n
j
3
0
1
4
8
.
P
e
t
h
i
d
i
n
e

(
H
,

R
)
N
B
I
M
,

S
C
0
.
5

m
g
/
k
g
/
d
o
s
e
6

P
R
N
A
m
p
5
0
A
n
t
i
d
o
t
e

n
a
l
o
x
o
n
e
,

n
a
l
o
r
p
h
i
n
e
.
I
N
,

C
H
S
C
,

I
M
1
-
1
.
5

m
g
/
k
g
/
d
o
s
e
4
-
6

P
R
N
M
a
y

p
r
o
d
u
c
e

s
e
i
z
u
r
e
s
,

c
o
m
a
i
n

s
e
n
s
i
t
i
v
e

p
a
t
i
e
n
t
s
.
1
4
9
.
P
h
e
n
o
b
a
r
b
i
t
o
n
e

(
H
,

R
)
S
u
s
p
2
0
A
m
p
2
0
0
P
o
r
p
h
y
r
i
a
A
n
t
i
c
o
n
v
u
l
s
a
n
t
P
O
4
-
6
1
2
-
2
4
U
n
s
u
i
t
a
b
l
e

f
o
r

l
o
n
g

t
e
r
m

u
s
e
S
t
a
t
u
s

e
p
i
l
e
p
t
i
c
u
s
I
V
1
0
-
2
0

m
g
/
k
g
i
f

p
r
o
d
u
c
e
s

h
y
p
e
r
a
c
t
i
v
i
t
y
,
l
o
a
d
i
n
g

f
o
l
l
o
w
e
d
i
r
r
i
t
a
b
i
l
i
t
y
b
y

5
-
1
0
m
g
/
k
g
/
d
o
s
e
/
P
R
N
;
m
a
x
i
m
u
m
4
0

m
g
/
k
g
/
t
o
t
a
l
1
5
0
.
P
h
e
n
o
x
y
b
e
n
z
a
m
i
n
e
I
n
i
t
i
a
l
P
O
0
.
2
6
-
1
2
C
a
p
1
0
C
o
n
t
r
o
l

o
f

h
y
p
e
r
t
e
n
s
i
o
n

i
n
M
a
i
n
t
e
n
a
n
c
e
1
-
2
6
-
1
2
p
h
e
o
c
h
r
o
m
o
c
y
t
o
m
a
1
5
1
.
P
h
e
n
y
t
o
i
n

(
H
,

R
)
M
o
n
i
t
o
r

h
e
a
r
t

r
a
t
e

c
a
n

b
e
S
t
a
t
u
s

e
p
i
l
e
p
t
i
c
u
s
N
B
,

I
N
,

C
H
I
V
1
5
-
2
0

m
g
/
k
g
/
T
a
b
1
0
0
d
i
l
u
t
e
d

w
i
t
h

s
a
l
i
n
e

b
u
t

n
o
t
l
o
a
d
i
n
g

d
o
s
e
S
u
s
p
1
2
5
/
5

m
L
w
i
t
h

d
e
x
t
r
o
s
e
.

C
/
I
-
P
o
r
p
h
y
r
i
a
(
<
1

m
g
/
k
g
/
m
i
n
)
8
-
1
2
3
0
/
5

m
L
B
l
o
o
d

l
e
v
e
l
s

i
n
c
r
e
a
s
e
d

b
y
L
o
n
g
-
t
e
r
m
N
B
,

I
N
,

C
H
P
O
3
-
8
1
2
-
2
4
A
m
p
5
0
d
e
x
a
m
e
t
h
a
s
o
n
e
.

V
e
r
y
e
f
f
e
c
t
i
v
e

f
o
r

d
i
g
o
x
i
n

i
n
d
u
c
e
d
V
e
n
t
r
i
c
u
l
a
r
N
B
,

I
N
,

C
H
I
V
a
r
r
h
y
t
h
m
i
a
s

a
n
d

l
a
t
e
t
a
c
h
y
a
r
r
h
y
t
h
m
i
a
O
v
e
r

5
2
-
4

m
g
/
k
g
/
d
o
s
e
v
e
n
t
r
i
c
u
l
a
r

a
r
r
h
y
t
h
m
i
a
s
m
i
n
s
(
>
0
.
5
f
o
l
l
o
w
i
n
g

r
e
p
a
i
r

o
f

c
o
n
g
e
n
i
t
a
l
m
g
/
k
g
/
m
i
n
)
c
a
r
d
i
a
c

d
e
f
e
c
t
s
.
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
763 763 763 763 763
Dosages of Some Common Drugs
763
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
b
l
o
c
k
1
5
2
.
P
h
y
s
o
s
t
i
g
m
i
n
e
C
H
I
M
,

I
V
0
.
0
0
1
-
0
.
0
3
R
e
p
e
a
t
A
m
p
S
C
m
g
/
k
g
/
d
o
s
e
q

1
5
-
2
0


m
i
n
t
o

d
e
s
i
r
e
d
e
f
f
e
c
t

o
r

a
m
a
x
i
m
u
m

d
o
s
e
o
f

2
0

m
g
1
5
3
.
P
i
p
e
r
a
c
i
l
l
i
n

(
R
)
N
B
I
M
,

I
V
1
0
0
1
2
V
i
a
l
1

g
E
f
f
e
c
t
i
v
e

a
g
a
i
n
s
t

K
l
e
b
s
i
e
l
l
a
(
1
5
-
3
0

m
i
n
)
a
n
d

P
s
e
u
d
o
m
o
n
a
s
;

c
o
n
t
a
i
n
s
1
.
8
5

m
E
q

N
a
/
g

s
a
l
t
.
I
N
,

C
H
2
0
0
-
3
0
0
4
-
6
1
5
4
.
P
r
a
l
i
d
o
x
i
m
e

(
P
A
M
)
I
V
,

I
M
2
5
-
5
0

m
g
/
k
g
/
s
t
a
t
.
R
p
t
.
8
-
1
2

h
r
V
i
a
l
1

g
A
n
t
i
d
o
t
e

f
o
r
(
R
)
(
5
-
1
0

m
i
n
)
P
R
N
o
r
g
a
n
o
p
h
o
s
p
h
a
t
e

p
o
i
s
o
n
i
n
g
.
1
5
5
.
P
r
a
z
o
s
i
n

(
R
)
I
n
i
t
i
a
l
C
H
P
O
0
.
1
6
T
a
b
0
.
5
,

1
,

2
D
o
s
e

m
a
y

b
e

i
n
c
r
e
a
s
e
d

u
p

t
o
M
a
i
n
t
e
n
a
n
c
e
0
.
1
-

0
.
4
6
1
5

m
g
;

o
r
t
h
o
s
t
a
t
i
c
(
M
a
x

d
a
i
l
y

d
o
s
e
h
y
p
o
t
e
n
s
i
o
n

c
o
m
m
o
n
=

2
0

m
g
)
1
5
6
.
P
r
e
d
n
i
s
o
l
o
n
e
I
N
,

C
H
P
O

(
P
C
)
1
-
2
6
-
8
T
a
b
5
,

1
0
,

2
0
A
c
t
i
v
i
t
y

o
f

s
t
e
r
o
i
d

i
s

r
e
d
u
c
e
d
b
y

r
i
f
a
m
p
i
c
i
n

a
n
d

h
y
d
a
n
t
o
i
n
.
M
a
y

f
l
a
r
e

u
p

T
B
,

o
t
h
e
r
i
n
f
e
c
t
i
o
n
s
.
1
5
7
.
P
r
i
m
a
q
u
i
n
e
I
N
,

C
H
P
O
0
.
5
5
O
D
T
a
b
2
6
.
5

m
g
C
/
I
-
G
6
P
D

d
e
f
i
c
i
e
n
c
y
(
=

0
.
3

m
g

b
a
s
e
)
=

1
5

m
g

b
a
s
e
1
5
8
.
P
r
o
c
a
i
n
a
m
i
d
e

(
R
)
I
N
,

C
H
P
O
2
0
-
3
0
4
-
6
T
a
b
2
5
0
T
o
o

r
a
p
i
d

o
r

o
v
e
r
d
o
s
e
I
V
3
-
6

m
g
/
k
g
/
d
o
s
e
I
n
j
.
1
0
0
p
r
o
d
u
c
e
s

h
y
p
o
t
e
n
s
i
o
n
;
f
o
l
l
o
w
e
d

b
y
M
o
n
i
t
o
r

b
l
o
o
d

p
r
e
s
s
u
r
e

a
n
d
c
o
n
t
i
n
u
o
u
s
Q
T

i
n
t
e
r
v
a
l

d
u
r
i
n
g

t
h
e
r
a
p
y
i
n
f
u
s
i
o
n

o
f

2
0
-
C
/
I
-
2
n
d
,

3
r
d

d
e
g
r
e
e

h
e
a
r
t
8
0

g
/
k
g
/
m
i
n
b
l
o
c
k
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
Principles of Pediatric and Neonatal Emergencies
764
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
1
5
9
.
P
r
o
p
o
f
o
l
C
H
I
V
1
.
5
-
3

m
g
/
k
g
/
d
o
s
e

V
i
a
l
1
0
0
,

2
0
0
,

5
0
0
H
y
p
o
p
e
r
f
u
s
i
o
n

m
a
y

o
c
c
u
r
;

i
n
o
v
e
r

1
-
2

m
i
n
c
r
i
t
i
c
a
l
l
y

i
l
l

c
h
i
l
d
r
e
n
,

p
r
o
p
o
f
o
l
C
o
n
t
i
n
u
o
u
s

s
e
d
a
t
i
o
n
5

m
g
/
k
g
/
h
r

f
o
r
i
n
f
u
s
i
o
n

s
y
n
d
r
o
m
e

(
a
c
u
t
e
3
0

m
i
n

g
r
a
d
u
a
l
l
y
b
r
a
d
y
c
a
r
d
i
a

p
r
o
g
r
e
s
s
i
n
g

t
o
i
n
c
r
e
a
s
e

t
o
a
s
y
s
t
o
l
e

c
o
m
b
i
n
e
d

w
i
t
h
1
2

m
g
/
k
g
/
h
r
l
i
p
e
m
i
c

p
l
a
s
m
a
,

f
a
t
t
y

l
i
v
e
r
e
n
l
a
r
g
e
m
e
n
t
,

m
e
t
a
b
o
l
i
c
a
c
i
d
o
s
i
s

w
i
t
h

n
e
g
a
t
i
v
e

b
a
s
e
e
x
c
e
s
s

>

1
0

m
m
o
l

(

1
)
,
r
h
a
b
d
o
m
y
o
l
y
s
i
s

o
r
m
y
o
g
l
o
b
i
n
u
r
i
a
)

h
a
s

b
e
e
n
r
e
p
o
r
t
e
d
.
1
6
0
.
P
r
o
p
r
a
n
o
l
o
l

(
R
,

H
)
S
u
p
r
a
v
e
n
t
r
i
c
u
l
a
r

a
n
d
N
B
I
V
0
.
0
5
-
v
e
n
t
r
i
c
u
l
a
r
(
1
0

m
i
n
)
0
.
1
5

m
g
/
k
g
/
d
o
s
e
t
a
c
h
y
c
a
r
d
i
a
R
p
t
.

a
f
t
e
r

1
0

m
i
n
s
t
h
e
n

8

h
r
.
6
-
8
T
a
b
1
0
,

4
0
C
/
I
-
A
s
t
h
m
a
,

C
C
F
.
I
N
,

C
H
P
O
0
.
5
-
1
6
-
8
I
n
j
.
1
I
V

(
1
0

m
i
n
s
)
0
.
0
1
-
0
.
1
/

m
g
/
k
g
/
P
R
N
P
r
e
v
e
n
t
i
o
n

o
f
I
N
,

C
H
d
o
s
e
6
-
8
c
y
a
n
o
t
i
c

s
p
e
l
l
P
O
4
6
A
n
t
i
h
y
p
e
r
t
e
n
s
i
v
e
P
O
0
.
5
-
2

















6
-
8
M
i
g
r
a
i
n
e

p
r
o
p
h
y
l
a
x
i
s
I
N
,

C
H
P
O
1
-
2

6
-
8
1
6
1
.
P
r
o
s
t
a
g
l
a
n
d
i
n

E
1
N
B
I
V
0
.
0
5
-
0
.
4

g
/
k
g
/
m
i
n
;
C
o
n
t
i
n
u
o
u
s
A
m
p
5
0
0

g
P
l
a
t
e
l
e
t

a
g
g
r
e
g
r
a
t
i
o
n

d
e
f
e
c
t
A
f
t
e
r

o
p
e
n
i
n
g

o
f
i
n
f
u
s
i
o
n
t
h
e

d
u
c
t
u
s
,

d
o
s
e
r
e
d
u
c
e
d

t
o
0
.
0
1

g
/
m
i
n
1
6
2
.
P
r
o
t
a
m
i
n
e

s
u
l
f
a
t
e
I
N
,

C
H
I
V
1

m
g

p
r
o
t
a
m
i
n
e
A
m
p
1
0

m
g
C
a
l
c
u
l
a
t
e

d
o
s
e

c
a
r
e
f
u
l
l
y
f
o
r

1
0
0

U

o
f
b
a
s
e
d

o
n

d
u
r
a
t
i
o
n

o
f

t
i
m
e
h
e
p
a
r
i
n
s
i
n
c
e

l
a
s
t

h
e
p
a
r
i
n

d
o
s
e

u
s
i
n
g
h
e
p
a
r
i
n

e
l
i
m
i
n
a
t
i
o
n

h
a
l
f

l
i
f
e
(
n
/
h
r
)

t
o

e
s
t
i
m
a
t
e

h
e
p
a
r
i
n
s
t
o
r
e
s
.
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
765 765 765 765 765
Dosages of Some Common Drugs
765
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
1
6
3
.
Q
u
i
n
i
d
i
n
e

(
H
,

R
)
I
N
,

C
H
P
O
3
0

m
g
/
k
g
/
d
a
y
4
-
6
T
a
b
2
0
0

(
s
u
l
f
a
t
e
)
Q
u
i
n
i
d
i
n
e

s
u
l
f
a
t
e

i
s

g
i
v
e
n
o
r
a
l
l
y

a
n
d

g
l
u
c
o
n
a
t
e

g
i
v
e
n
I
M
,

I
V
.

T
e
s
t

d
o
s
e

o
f

2

m
g
/
k
g
I
N
,

C
H
I
M
,

I
V
2
-
1
0

m
g
/
k
g
/
d
o
s
e
3
-
6
I
n
j
8
0

(
g
l
u
c
o
n
a
t
e
)
g
i
v
e
n

P
O

t
o

e
x
c
l
u
d
e
P
R
N
i
d
i
o
s
y
n
c
r
a
s
y
.

N
o
t

t
o

b
e

g
i
v
e
n
i
n

n
e
o
n
a
t
e
s
;

E
r
r
a
t
i
c
a
b
s
o
r
p
t
i
o
n

w
i
t
h

I
M

u
s
e
.
P
r
e
f
e
r
r
e
d

f
o
r

o
r
a
l

u
s
e

o
n
l
o
n
g

t
e
r
m
.
1
6
4
.
Q
u
i
n
i
n
e

s
u
l
p
h
a
t
e
I
N
,

C
H
P
O
2
5
-
3
0
8
T
a
b
1
5
0
,

3
0
0
Q
u
i
n
i
n
e

d
i
h
y
d
r
o
c
h
l
o
r
i
d
e

1
2
m
g

=

1
0

m
g

b
a
s
e
Q
u
i
n
i
n
e
I
N
,

C
H
I
V
2
0

m
g
/
k
g

s
a
l
t
A
m
p
3
0
0
A
r
r
h
y
t
h
m
i
a
s

a
n
d

h
y
p
o
t
e
n
s
i
o
n
d
i
h
y
d
r
o
c
h
l
o
r
i
d
e
d
i
l
u
t
e
d
m
a
y

o
c
c
u
r
,

m
o
n
i
t
o
r

b
l
o
o
d
(
c
o
n
c

1

m
g
/
m
L

o
f
s
u
g
a
r

f
o
r

h
y
p
o
g
l
y
c
e
m
i
a
.
s
a
l
i
n
e
)
o
v
e
r

4

h
r

a
s
l
o
a
d
i
n
g

t
h
e
n

1
0
m
g

b
a
s
e
/
k
g

8
h
o
u
r
l
y

a
s

4

h
r
i
n
f
u
s
i
o
n
1
6
5
.
R
a
n
i
t
i
d
i
n
e

(
H
,

R
)
N
B
,

I
N
,

C
H
I
V
1
-
3
6
-
1
2
T
a
b
1
5
0
,

3
0
0
P
O
2
-
6
8
-
1
2
A
m
p
2
5
1
6
6
.
R
i
b
a
v
i
r
i
n

(
H
,

R
)
I
N
,

C
H
P
O
1
0
6
-
8
C
a
p
1
0
0
,

2
0
0
6

g

p
o
w
d
e
r

i
s

d
i
s
s
o
l
v
e
d

i
n
S
y
r
5
0
3
0
0

m
l

w
a
t
e
r
.

N
e
b
u
l
i
s
e
d

f
o
r
P
o
w
d
e
r
6

g
1
2
-
1
8

h
r
/
2
4

h
r

f
o
r

3
-
7

d
a
y
s
.
F
o
r

R
S
V

b
r
o
n
c
h
i
o
l
i
t
i
s
.
1
6
7
.
S
a
l
m
e
t
e
r
o
l
I
N
,

C
H
I
n
h
a
l
a
t
i
o
n
5
0
-
1
0
0

g
/
d
1
2
M
D
I
2
5

g

p
e
r

a
c
t
u
a
t
i
o
n
1
6
8
.
S
p
i
r
o
n
o
l
a
c
t
o
n
e

(
R
)
C
H
P
O
1
.
5
-

3
6
-

1
2
T
a
b
2
5
,

1
0
0
C
/
I
-
H
y
p
e
r
k
a
l
e
m
i
a
,

r
e
n
a
l
f
a
i
l
u
r
e
.
1
6
9
.
S
u
c
c
i
n
y
l

c
h
o
l
i
n
e

(
H
)
I
n
,

C
H
I
V
1
-

2

m
g
/

k
g
/

d
o
s
e
;
P
R
N
I
n
j
2
0

m
g
/

m
L
;
m
a
i
n
t
e
n
a
n
c
e
:

0
.
3
-
5
0

m
g
/

m
L
0
.
6

m
g
/

k
g
/

d
o
s
e
e
v
e
r
y

5
-
1
0

m
i
n
1
7
0
.
S
u
l
f
a
d
o
x
i
n
e

+
I
N
,

C
H
P
O
1
.
2
5

m
g
/
k
g

o
f
O
D
T
a
b
2
5

o
f

p
y
r
F
o
r

c
h
l
o
r
o
q
u
i
n
e

r
e
s
i
s
t
a
n
t
P
y
r
i
m
e
t
h
a
m
i
n
e

(
R
)
p
y
r
i
m
e
t
h
a
m
i
n
e
S
y
r
2
5

o
f

p
y
r
/
m
a
l
a
r
i
a
1
0

m
L
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
Principles of Pediatric and Neonatal Emergencies
766
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
1
7
1
.
S
u
l
f
a
m
e
t
h
o
x
a
z
o
l
e
-
I
N

(
>

2

m
o
)
P
O
6
-
1
2

T
M
P
1
2
S
y
r
4
0

T
M
P
I
V

p
r
e
p
a
r
a
t
i
o
n

t
o

b
e

d
i
l
u
t
e
d
T
r
i
m
e
t
h
o
p
r
i
m

(
H
,

R
)
C
H
3
0
-
6
0

S
M
X
2
0
-
2
5

t
i
m
e
s

a
n
d

a
d
m
i
n
i
s
t
e
r
e
d
S
e
v
e
r
e

U
T
I

a
n
d
8
-
1
0

T
M
P
6
-
8
P
e
d

T
a
b
2
0
,

4
0

T
M
P
a
s

i
n
f
u
s
i
o
n
.
S
h
i
g
e
l
l
o
s
i
s
4
0
-
5
0

S
M
X
T
a
b
8
0
,

1
6
0

T
M
P
P
.

j
i
r
o
v
e
c
i

i
n
f
e
c
t
i
o
n
I
V
1
5
-
2
0

T
M
P
I
n
j
1
6

m
g
/
m
L

(
I
V
)
(
6
0
-
9
0

m
i
n
)
7
5
-
1
0
0

S
M
X
6
-
8
1
7
2
.
T
e
r
b
u
t
a
l
i
n
e

(
R
)
C
H
P
O
0
.
1
-
0
.
1
5
T
a
b
s
2
.
5
,

5
B
e
i
n
g

s
e
l
e
c
t
i
v
e

b
l
o
c
k
e
r
,

i
s
S
C
0
.
0
1
-
0
.
0
2

m
g
/
k
g
/
S
y
r
1
.
5
m
o
r
e

p
o
t
e
n
t

t
h
a
n

a
d
r
e
n
a
l
i
n
e
d
o
s
e
A
m
p
0
.
5
i
n

e
q
u
i
v
a
l
e
n
t

d
o
s
e
.
N
e
b
u
l
i
z
a
t
i
o
n
N
e
b
u
l
i
z
e
r

s
o
l
n
1
0

m
g
/
m
L
S
u
b
s
e
q
u
e
n
t

S
C

d
o
s
e
s

m
a
y
5
-
8

g
/
k
g
b
e

r
e
p
e
a
t
e
d

a
t

1
5
-
2
0

m
i
n
u
t
e
s
i
n
h
a
l
a
t
i
o
n

a
t
i
n
t
e
r
v
a
l
.
a

t
i
m
e
1
7
3
.
T
e
t
a
n
u
s
N
B
,

I
N
,

C
H
I
M
5
0
0
-
3
0
0
0

U
S
t
a
t
V
i
a
l
2
5
0

U
N
o
t

t
o

b
e

g
i
v
e
n

I
V
;
i
m
m
u
n
o
g
l
o
b
u
l
i
n
r
e
f
r
i
g
e
r
a
t
e
P
r
o
p
h
y
l
a
x
i
s
4

U
/
k
g
1
7
4
.
T
h
e
o
p
h
y
l
l
i
n
e

(
H
)
T
a
b
,

S
y
r
O
f

v
a
r
i
a
b
l
e
T
h
e
o
p
h
y
l
l
i
n
e

c
o
n
c
e
n
t
r
a
t
i
o
n

o
f
S
t
r
e
n
g
t
h
s
a
m
i
n
o
p
h
y
l
l
i
n
e

i
s

8
5
%
,
A
s
t
h
m
a
t
i
c
u
s
2
0
6
m
o
n
o
e
t
h
a
n
o
l
a
m
i
n
e

s
a
l
t

7
5
%
M
a
i
n
t
e
n
a
n
c
e
1
0
6
a
n
d

c
h
o
l
i
n
e

s
a
l
t

6
4
%
.

S
w
i
t
c
h
N
e
o
n
a
t
a
l

a
p
n
e
a
t
o

o
r
a
l

a
s

e
a
r
l
y

a
s

p
o
s
s
i
b
l
e
.
<

3
6

w
k
P
O
1
-
2

m
g
8
-
1
2
>

3
6

w
k
P
O
2
-
4

m
g
8
-
1
2
C
/
I
-
c
a
r
d
i
a
c

a
r
r
h
y
t
h
m
i
a
s
.
E
r
y
t
h
r
o
m
y
c
i
n
,

c
i
p
r
o
f
l
o
x
a
c
i
n
c
a
u
s
e

i
n
c
r
e
a
s
e
d

s
e
r
u
m
c
o
n
c
e
n
t
r
a
t
i
o
n
s
.
1
7
5
.
T
h
i
o
p
e
n
t
o
n
e

(
H
,

R
)
C
H
I
V
5

m
g
/

k
g

l
o
a
d
i
n
g
V
i
a
l
5
0
0
,

1
0
0
0
R
e
f
r
a
c
t
o
r
y

s
t
a
t
u
s
d
o
s
e

f
o
l
l
o
w
e
d

b
y
e
p
i
l
e
p
t
i
c
u
s
0
.
5
-
4

m
g
/
k
g
/
h
r
1
7
6
.
T
h
y
r
o
x
i
n
e
N
B
P
O
1
0
-
1
5

g
O
D
T
a
b
2
5
,

5
0
,

1
0
0
,
>

1
-
2

y
r
s
P
O
5

g
2
0
0

g
1
7
7
.
T
o
b
r
a
m
y
c
i
n

(
R
)
N
B
S
e
e
n
e
w
b
o
r
n
t
a
b
l
e
I
N
,

C
H
I
M
,

I
V
5
-
7
.
5
8
-
1
2
A
m
p
1
0
,

2
0
,

4
0
(
3
0
-
6
0

m
i
n
)
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
767 767 767 767 767
Dosages of Some Common Drugs
767
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
1
7
8
.
T
r
i
a
m
t
e
r
e
n
e

(
H
,

R
)
C
H
P
O
2
-
4

(
m
a
x
.

6
)
1
2
-
2
4
T
a
b
5
0
C
o
m
b
i
n
e
d

w
i
t
h

B
e
n
z
t
h
i
a
z
i
d
e
.
C
/
I
-
R
e
n
a
l

f
a
i
l
u
r
e
,
h
y
p
e
r
k
a
l
e
m
i
a
.
1
7
9
.
T
r
i
c
l
o
f
o
s
S
l
e
e
p
I
N
,

C
H
P
O
2
0
-
4
0

m
g
/
k
g
/
d
o
s
e
S
y
r
5
0
0
C
/
I
-
s
e
v
e
r
e

h
e
p
a
t
i
c

o
r

r
e
n
a
l
i
m
p
a
i
r
m
e
n
t
.
S
e
d
a
t
i
o
n
1
0
-
2
0

m
g
/
k
g
/
d
o
s
e
1
8
0
.
V
a
l
p
r
o
i
c

a
c
i
d

(
H
)
C
H
P
O
1
5
8
-
1
2
T
a
b
2
0
0
M
a
y

r
e
t
a
r
d

h
e
p
a
t
i
c

d
r
u
g
1
0
1
2
S
y
r
2
0
0
m
e
t
a
b
o
l
i
z
i
n
g

e
n
z
y
m
e
s
.
I
n
c
r
e
a
s
e
s

l
e
v
e
l

o
f
I
n
c
r
e
a
s
e
p
h
e
n
o
b
a
r
b
i
t
o
n
e
.

M
a
y
w
e
e
k
l
y

b
y
p
r
e
c
i
p
i
t
a
t
e

a
b
s
e
n
c
e

s
t
a
t
u
s
5
-
1
0

m
g
/
k
g
i
f

u
s
e
d

w
i
t
h

c
l
o
n
a
z
e
p
a
m
.
u
p

t
o

3
0
-
6
0
C
h
i
l
d
r
e
n

<
2

y
r

m
a
y

h
a
v
e
f
a
t
a
l

h
e
p
a
t
i
c

d
y
s
f
u
n
c
t
i
o
n
.
C
/
I
-
H
e
p
a
t
i
c

d
y
s
f
u
n
c
t
i
o
n
.
1
8
1
.
V
a
n
c
o
m
y
c
i
n

(
R
)
N
B

<

1

w
k
I
V
2
0
-
3
0
1
2
V
i
a
l
5
0
0
>

1

w
k
2
0
-
3
0
8
C
a
p
1
2
5
,

2
5
0
U
s
e
f
u
l

f
o
r
p
s
e
u
d
o
m
e
m
b
r
a
n
o
u
s
I
N
,

C
H
P
O
,

I
V
4
0
-
6
0
6
e
n
t
e
r
o
c
o
l
i
t
i
s
;

d
r
u
g

o
f

c
h
o
i
c
e
P
s
e
u
d
o
m
e
m
b
r
a
n
o
u
s
1
0
4
0
-
5
0
6
-
8
f
o
r

m
e
t
h
i
c
i
l
l
i
n

r
e
s
i
s
t
a
n
t
c
o
l
i
t
i
s
S
t
a
p
h
y
l
o
c
o
c
c
u
s

a
u
r
e
u
s
.
1
8
2
.
V
a
s
o
p
r
e
s
s
i
n

(
H
)
A
q
u
e
o
u
s

v
a
s
o
p
r
e
s
s
i
n

5
-
1
0
D
i
a
b
e
t
e
s

i
n
s
i
p
i
d
u
s
S
C
,

I
M
5
-
1
0

U
/
d
o
s
e
4
A
m
p

(
2
0

u
n
i
t
s
/
m
L
)
u
n
i
t
s

m
a
y

b
e

t
r
i
e
d

t
o
d
i
f
f
e
r
e
n
t
i
a
t
e

c
e
n
t
r
a
l

f
o
r
m
n
e
p
h
r
o
g
e
n
i
c

d
i
a
b
e
t
e
s
B
l
e
e
d
i
n
g

e
s
o
p
h
a
g
e
a
l
I
V
0
.
3
3

U
/
k
g

i
s
i
n
s
i
p
i
d
u
s
.
v
a
r
i
c
e
s
l
o
a
d
i
n
g

f
o
l
l
o
w
e
d
b
y


0
.
0
0
2
-
0
.
0
1
U
/
k
g
/
m
i
n
1
8
3
.
V
e
c
u
r
o
n
i
u
m

(
H
,

R
)
N
B
,

I
N
,

C
H
I
V
0
.
1

m
g
/
k
g
/
d
o
s
e
P
R
N
f
o
l
l
o
w
e
d

b
y

0
.
0
5
-
0
.
1

m
g
/

k
g
/

d
o
s
e
e
v
e
r

1
-

2

h
r
.
I
n
f
u
s
i
o
n
:

1
-

1
.
5

g
/
k
g
/
m
i
n
C
o
n
t
d
.
.
.
C
o
n
t
d
.
.
.
Principles of Pediatric and Neonatal Emergencies
768
(
1
)
(
2
)
(
3
)
(
4
)
(
5
)
(
6
)
(
7
)
(
8
)
(
9
)
1
8
4
.
V
e
r
a
p
a
m
i
l

(
H
,

R
)
I
N
I
V
0
.
1
-
0
.
2

m
g
/
k
g
T
a
b
4
0
,

8
0
C
/
I
-
c
a
r
d
i
o
g
e
n
i
c

s
h
o
c
k
,

A
V
o
v
e
r

2

m
i
n
s
1
2
0
b
l
o
c
k
,

s
i
c
k

s
i
n
u
s

s
y
n
d
r
o
m
e
.
A
m
p
2
.
5
A
v
o
i
d

u
s
e

i
n

n
e
o
n
a
t
e

a
n
d
C
H
I
V
0
.
1
-
0
.
3

m
g
/
k
g
i
n
f
a
n
t
s
,

h
y
p
o
t
e
n
s
i
o
n

o
r
o
v
e
r

2

m
i
n
s
b
r
a
d
y
c
a
r
d
i
a
;

a
n
t
i
d
o
t
e
-
c
a
l
c
i
u
m
M
a
i
n
t
e
n
a
n
c
e
P
O
1
-
2
8
g
l
u
c
o
n
a
t
e
.
1
8
5
.
V
i
t

K
N
B
0
.
5
-
1

m
g

s
t
a
t
A
m
p
1
0

m
g
/
m
L
P
r
o
p
h
y
l
a
x
i
s
I
N
,

C
H
1
-
2

m
g

s
t
a
t
T
h
e
r
a
p
e
u
t
i
c
N
B
,

I
N
,

C
H
2
-
1
0

m
g
/
d
o
s
e

O
D
f
o
r

3

d
a
y
s
1
8
6
.
V
o
r
i
c
o
n
a
z
o
l
e

(
H
,

R
)
I
N
,

C
H
I
V
L
o
a
d
i
n
g

d
o
s
e
:

6
1
2
V
i
a
l
2
0
0
m
g
/
k
g
/
d
o
s
e

2
d
o
s
e
s
.
M
a
i
n
t
e
n
a
n
c
e
:

8
1
2
1
8
7
.
W
a
r
f
a
r
i
n

(
H
,

R
)
C
H
P
O
0
.
0
5
-

0
.
3
2
4
T
a
b
5
P
r
o
t
h
r
o
m
b
i
n

t
i
m
e

t
o

b
e
m
a
i
n
t
a
i
n
e
d

a
t

1
.
5
-

2

t
i
m
e
s
n
o
r
m
a
l
.